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ABSTRACT

Prabhu Verleker, Akshay N. Ph.D., Purdue University, August 2016. A Therapeutic
Protocol for Treatment of Brain Metastasis through Optically Stimulated Drug Release.
Major Professor: Keith Stantz.

Purpose: The long-term goal of this research is to determine the feasibility of using near
infra-red light to stimulate drug release in metastatic lesions within the brain. In this
work, we focused on developing the tools needed to quantify and verify photon fluence
distribution in biological tissue. To accomplish this task, an optical dosimetry probe and
Monte Carlo based simulation code were fabricated, calibrated and developed to
predict light transport in heterogeneous tissue phantoms of the skull and brain.
Empirical model (EM) of photon transport using CT images as input were devised to
provide real-time calculations capable of being translated to preclinical and clinical
applications.

Methods and Materials: A GPU based 3D Monte Carlo code was customized to simulate
the photon transport within head phantoms consisting of skull bone, white and gray
matter with differing laser beam properties, including flat, Gaussian, and superGaussian profiles that are converging, parallel, or diverging. From these simulations, the
local photon fluence and tissue dosimetric distribution was simulated and validated

xx
through the implementation of a novel titanium-based optical dosimetry probe with an
isotropic acceptance and 1.5mm diameter. Empirical models (EM) of photon transport
were devised and calibrated to MC simulated data to provide 3D fluence and optical
dosimetric maps in real-time developed around on a voxel-based convolution technique
Optical transmission studies were performed using human skull bone samples to
determine the optical transmission characteristics of heterogeneous bone structures
and the effectiveness of the Monte Carlo in simulating this heterogeneity. These tools
provide the capability to develop and optimize treatment plans for optimal release of
pharmaceuticals to metastatic breast cancer in the brain.

Results: At the time of these experiments, the voxel-based CUDA MC code implemented
and further developed in this study had not been validated by measurement. A novel
optical dosimetry probe was fabricated and calibrated to measure the absolute photon
fluence (mW/mm2) in phantoms resembling white matter, gray matter and skull bone
and compared to 3D Monte Carlo simulated data. The TiO2-based dosimetry probe was
shown to have superior linearity and isotropicity of response to previous Nylon based
probes, and was better suited to validate the Monte Carlo using localized 3D
measurement (< 25% systematic error for white matter, gray matter and skull bone
phantoms along illumination beam axis up to a depth of 2cm in homogeneous tissue
and 3.8cm in heterogeneous head phantom). Next, the transport parameters of the
empirical algorithm was calibrated using the 3D Monte Carlo and EMs and validated by

xxi
optical dosimetry probe measurements (with error of 10.1% for White Matter, 45.1%
for Gray Matter and 22.1% for Skull Bone phantoms) along illumination beam axis.

Conclusions: The design and validation of the Monte Carlo, the optical dosimetry probe
and the Empirical algorithm increases the clinical feasibility of optical therapeutic
planning to narrow down the complex possibilities of illumination conditions, further
compounded by the heterogeneous structure of the brain, such as varying skull
thicknesses and densities. Our ultimate goal is to design a fast Monte Carlo based
optical therapeutic protocol to treat brain metastasis. The voxelated nature of the MC
and EM provides the necessary 3D photon distribution to within 25% error to guide
future clinical studies involving optically triggered drug release.

1

1

INTRODUCTION

1.1

Overview

The purpose of our research involves the development of optical dosimetry and
simulation tools to quantify and optimize the delivery of light to brain tissues. We start
by introducing the concept of optically stimulated drug release for treatment of
cancerous lesions in the brain. This mode of therapy requires an efficient optical
planning system to determine the best modes of illumination to target tissues in the
brain. Such a planning system applies the physics of optical transport to determine the
photon distribution in complex heterogeneous media characterized by clinical imaging
methods, such as CT and MRI. Critical is the need to validate these methods in tissue
phantoms and to determine their accuracy and precision. To realize these ideas into
planning systems, which require multiple sources and optimization algorithms, require
fast execution times not afforded by MC codes. An Empirical algorithm can achieve
these fast simulation speeds. Ultimately, these simulation tools are validated in tissue
phantoms using a novel optical dosimetry probe with a Titanium Dioxide with a linear
and isotropic response.
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1.2

Application in Optically Stimulated Drug Release

To date, brain cancer remains a sanctuary for metastasis. Treatment of Central Nervous
System (CNS) metastasis poses a critical clinical challenge due to limitations in drug
uptake in the brain (across the blood brain barrier and blood-cerebrospinal fluid barrier)
and adverse neurotoxic effects of mainstay therapies, such as whole brain radiation
therapy (WBRT) and stereotactic radiosurgery [1-8]. Recently, receptor targeted therapy
aided by improved imaging and localized radiotherapy has shown promise in treating
cancer within the brain. This is particularly true for HER2+ breast cancer metastasis,
which have poor median survival rates of 2 to 16 months [1-7]. Therefore, Dr. Susan
Clare, a Surgeon at Northwestern University Robert H Lurie Medical Research Center,
devised a method where a patient’s macrophages and monocytes are loaded with a
drug payload, in this case a lapatinib laden nanoparticle, to actively delivery and target
the metastatic cancer cells. The ‘Trojan Horse’ concept has shown significant promise in
targeted drug delivery to the brain, with metastatic cells retaining their sensitivity to the
drug even after its administration [8, 9]. The use of macrophages as drug carriers has
been proved to be a potentially effective tool because macrophages have been seen to
comprise up to 70% of volume in cancerous tumors, such as breast cancer [10-13]. The
quantification of macrophages in different tumor types can be done using mouse
monoclonal antibody EBM/11 [14, 15], and is an important process in determining the
therapeutic accuracy of this potential treatment.

3
This idea was demonstrated by replacing labeling the payload with fluorescent
molecules and showing uptake and fluorescence in brain metastasis of mice, which was
published in Cancer Nanotechnology [8, 9]. The long-term goal of this study is to deliver
lapatinib-gold nanocomplex laden macrophages to brain metastasis and design a
therapeutic protocol to optically stimulate drug release in target tissues in the brain.
With the rate and quantity of drug release being directly dependent on the optical
power delivered, an optical simulation protocol using Monte Carlo simulations can be
designed to effectively predict the photon distribution and subsequent drug activation
in the brain tissue.

5
1.3

Applications Requiring Quantification of NIR Light Delivery

While the primary purpose of this research was to enable the quantification of photon
propagation in heterogeneous brain tissues, it can be easily applied to NIR based
imaging techniques such as Photoacoustic Tomography (PCT), Near Infra-Red
Spectroscopy (NIRS) and in optical stimulation of neurons in the brain. The use of the
Monte Carlo and the optical dosimetry probe in absolute quantification of photon
fluence in tissues can provide the necessary corrections and validation to quantify
molecular concentrations in vivo and to deliver the necessary photon dose to trigger
therapeutic effects.

Photoacoustic effect involves the absorption of light energy by a molecule, which leads
to a thermal heating and volumetric expansion. The generated acoustic wave usually in
the ultrasound frequency range is proportional to the optical energy absorbed or dose,
and thus a molecule’s concentration such as hemoglobin and injectable dyes. This has
led to both clinical and pre-clinical applications such as breast cancer imaging, small
animal studies, hemoglobin concentration, oxygen saturation, blood perfusion imaging
etc. [16-20]. The application of optical Monte Carlo based methods in Photoacoustic
imaging has shown promising results in improving the estimation of photon propagation
in complex tissues being imaged [21-26].

Another imaging modality which widely used the penetrating ability of NIR light in
tissues, particularly in the brain, is NIR Spectroscopy. The NIR Spectroscopy uses a
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source and a detector placed on the surface of the brain. The light gets transmitted
through the skull and after undergoing multiple absorption, scattering and refraction
events, gets measured by another detector placed on the skull surface near the source.
The changes in blood oxygenation in the brain leads to changes in light absorption and
can be monitored through the signal detected at various stages of brain activation,
initially reported by Jobsis in 1977 [27]. It uses a modified Beer-Lambert’s law for high
scattering brain tissues [28, 29]. This technique was initially used to map brain function
of cortical tissues in animal and human subjects [30, 31], and later in brain functions of
intact skulls in human adults [32-36]. Various applications include monitoring
intracellular physiological processes in the brain cells and in measuring Cerebral Blood
Flow (CBF) and Cerebral Blood Volume (CBV) [37-40]. Hence the use of Monte Carlo
estimation methods for complex 3D photon propagation along with the optical
dosimetry methods can improve the accuracy of the fNRIS measurements by providing
absolute quantification of photon fluence.

NIR neural stimulation is another method which requires knowledge of the optical dose
in the brain. The use of pulsed infra-red lasers has been shown to trigger the excitation
of neurons at a certain optical threshold [41]. This effect has been observed to be
wavelength dependent and is seen by measuring the compound action potential (CAP)
linked to Ca+2 ions in neural mitochondria [41]. Various studies in tissues samples and
in-vivo have been carried out to monitor this effect and measure the electrical activity
of the brain [42-49]. The use of Monte Carlo methods with wavelength dependent
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absorption simulation techniques can provide the necessary information to correlate
the electrical activity in brain tissue, such as the cochlea and neuro-prosthesis.

1.4

Light Transport Theory

The radiative transport equation describes the propagation of light through media and is
considered to be more accurate as it takes into account the absorption and scattering of
light in heterogeneous media [50, 51].
s. L(r, s) =

( +  )L(r, s) +   p(s, )L(r, )d,

(1.1)

where L(r,s) is the radiance (units: W.m-2.sr-1) at position r, in the direction s (unit vector)
in a medium with an absorption coefficient of a and scattering coefficient of μs.
Radiance itself is defined as the radiant flux (Watts/sec) emitted, transmitted or
received by a surface per unit solid angle, per unit projected area [50, 51]. The total
attenuation coefficient (μt) is the sum of the absorption (μa) and scattering (μs)
coefficients (units: m-1). Equation 1.6 describes the change in radiance due to absorption
and scattering out of or into a volume. The differential solid angle d is in the direction
of s’ and p(s,s’) refers to the phase function, which is the probability of a photon
travelling in direction s’ being scattered into direction s. or characterized by the
parameter g (anisotropy factor), the cosine average of the phase function:
g =  p(s, )(s. )d.

(1.2)

The value of the parameter g describes the scattering, for example forward scatter
means g=1, isotropic scatter by g=0 and backscatter by g=-1.
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The radiative transport theory assumes a homogeneous distribution of the scattering
and absorbing particles in the medium. This assumption and the quantification of the
scattering and absorption coefficients can help predict the fluence distribution and the
absorbed energy in the medium. There are several approximations to solving the
transport equation depending on the type of irradiance (e.g. diffuse or collimated) and
optical boundary conditions [50, 51]. For depths far from the light source, there are two
solutions which account for un-scattered transmission and an asymptotic fluence-rate:
the Beer Lambert’s law and the Diffusion approximation. The Beer Lambert’s law
describes the transmission of light through a non-scattering medium:
T=e

,

(1.3)

where t is the thickness or path-length, T is the fraction of the intensity transmitted
through the medium and  is the total attenuation coefficient.

A further modification of the Beer’s Law is made to account for two scattered
components [51]:
L(r, s) = L (r, s) + L (r, s),

(1.4)

where Lc is the light that did not interaction with tissue while Ld is the part that
underwent scattering. Thus using this diffuse theory approximation in the RTE equation,
the fluence can be simplified to [51]:

(r) =  L (r, s)d.

(1.5)
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The diffuse approximation is affected by the ratio of scattering-to-absorption
coefficients, the tissue distance from the light source, the boundaries and the
anisotropy factor [52]. A phase function compatible with the diffusion equation is the
Henyey-Greenstein function (pHG) [53, 54]:


 (,   ) = ( )  (2 + 1)  (,   ),

(1.6)

where Pn are the Legendre polynomials. The phase function given by the deltaEddington approximation, combines both the diffusion and forward scatter terms, and is
given by [55]:

(,   ) =  (    ) + (1  ) (, ), (1.7)
where f is the forward scatter amount and p1 are the first two terms of the Legendre
polynomial. The delta-Eddington phase function makes use of the Henyey-Greenstein
phase function and is found to be ideal for light propagation in tissues. This is done by
the following substitutions [53, 55]:


 = g

(1.8)

 (1  g  ) = 

(1.9)

Thus, the total fluence rate in a material of finite depth is [56]

(z) = a exp(kz) + a exp(kz) + a exp( z),

(1.10)

where z is the depth and k is approximately equal to  !! . This condition is valid only if
the absorption coefficient is significantly lower than the scattering coefficient. As per
the diffusion theory, the transmittance T and reflectance R are given by [57 - 60]:
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(a ke

a  e  ) (1.11)

a ke
and

R=

( )

+ h/2(a k

a k

a k).

(1.12)

The optical    s),   a), anisotropy
factor (g)) can be calculated using the total reflectance and transmission. The reduced
scattering coefficient s’)   !  "   s) as follows [61, 62]:
# = (1

g)#

(1.13)

For complex heterogeneous tissues, the relation between reflectance, transmission and
the three optical parameters become complicated. A unique computation method used
to simulate the random walk of photons across complex heterogeneous media is the
Monte Carlo based on $s, $a, g, n, and p(s,s’)

1.5

A GPU based 3D Monte Carlo for photon transport

The Monte Carlo model uses a random number generator to simulate the transport of
photons in optical media [57-60] based on the absorption coefficient (μa), scattering
coefficient (μs), anisotropy factor (g) and the index of refraction (n). A 3D voxel based
Monte Carlo allows simulation of complex geometrical boundaries, with each voxel
having unique optical properties (μa, μs, g, n) [59] A packet of photons is assigned an
initial weight and direction, and propagate from one voxel to another, while depositing
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energy in each voxel based on its absorption coefficient. The photons also scatter within
voxels after travelling a pre-determined distance based on the scattering coefficient of
the medium. The new direction of the scattered photon is determined by the anisotropy
factor (g) which is the cosine of the phase function [57]. Finally, when the weight of the
photon reaches a pre-determined threshold, it is extinguished. The weights deposited
by all the photons in each voxel are accumulated to determine the energy deposited,
while the total number of photons passing through the voxel is its fluence rate
(photons/mm2.s) [61].

Traditional CPU based Monte Carlo models [57, 59] suffer from slow computation
speeds, which makes them non-viable for application in clinical settings, especially in
highly scattering tissues, such as white matter. The GPU based 3D Monte Carlo code
used in these studies was shown to be 300X faster compared to our previous CPU based
models [61]. The CUDA acceleration provided by this model helps to achieve complete
brain simulation of a high fluence broad beam source within hours, as compared to days
of simulation time using CPU based models [61 - 63]. This model also provides a voxel
based 3D distribution of photon fluence and energy deposited, and can be coregistered
with different medical imaging modalities (e.g. CT, MR, Ultrasound, etc.), thus improving
its clinical viability for diagnosis and therapy [62, 63].
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1.6

An Empirical Photon Propagation Algorithm

While Monte Carlo is the gold standard for photon propagation, it has long execution
times even with the acceleration provided by the GPU based models. For high scattering
tissues, such as white matter and skull bone, the simulation time for a broad beam
simulation is on the order of several hours (based on beam diameter) in order to
achieve statistically significant results at depths of more than 2cm [63, 64]. Thus for
applications involving optical illumination planning for therapy, where multiple
simulations are required for optimizing light delivery to tissues at 5-8cm in depth with
complex geometry and heterogeneity, a fast alternate approach is required, particularly
for protocols requiring multiple beams [63]. We therefore designed an algorithm based
on an empirical model (EM) that simulates photon propagation in heterogeneous
voxelated optical media [63, 64].

The EM algorithm implements a convolution technique where the photon fluence within
a voxel is the sum of the weighted fluence in neighboring voxels. It simulates photon
scatter by assigning weights for forward, diagonal, side and back scatter directions [64].
The fluence within a voxel is assumed to be made of directional components in the x, y,
and z directions to emulate the Henyey-Greenstein function. The fluence entering a
voxel is redistributed into these directional components such that the sum of the
weights is conserved prior to absorption. The scatter weights are determined by
comparing the photon fluence distribution with the Monte Carlo under similar
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illumination and boundary conditions, before being applied to complex heterogeneous
media [64].

The Empirical algorithm provides a fast approach to simulate complete 3D simulations
at a fraction of the time (seconds) compared to the Monte Carlo (hours) in complex 3D
media (e.g. brain) [63, 64]. This allows us to evaluate multiple illumination conditions for
an optical therapeutic protocol for optimized light delivery to tissues within clinically
relevant time frames. The 3D voxel based empirical approach also allows for easy
integration of the simulated photon energy dose maps with existing imaging modalities,
e.g., CT, MR, Ultrasound, Photoacoustic Computed Tomography, which improves
therapeutic planning accuracy [63]. Thus the empirical approach can be used a
preliminary tool to narrow down the possible illumination conditions, while the Monte
Carlo can be used to finalize and quantify the estimated fluence for optical therapy. This
makes the use of optical simulation techniques more attractive in clinical settings by
reducing the simulation times involved, and is a core purpose of our research.

1.7

A Titanium Dioxide based Optical Dosimetry Probe

Optical dosimetry involves measuring the localized photon fluence in media such as
tissues or tissue phantoms. An optical dosimetry probe is a device which consists of a
bulb of highly scattering material attached to the exposed tip of an optical fiber, with
the other end of the fiber is connected to a photodiode circuit which is in turn
connected to an oscilloscope. The light is conducted by the optical fiber to the PIN
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photodiode where it is converted into an electrical signal. The dosimetry probe is
preferred over calorimeters due to the smaller size, higher sensitivity, and isotropic
response of the probe in an aqueous (or liquid) media. In this study, we fabricated an
optical dosimetry probe with better isotropicity and locality compared to previous
designs of Nylon based probes. The dosimetry probe was used to validate the fluence
generated by the Monte Carlo simulation in homogeneous and heterogeneous braintissue phantoms. The optical sensitivity of the probe enabled us to validate extremely
low fluence in tissue phantoms, unlike the calorimeter.
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2

SPECIFIC AIMS

In Chapter 1, quantifying the photon fluence within a heterogeneous tissue is important
for applications including controlled drug release, neuro-stimulation and therapy, and
molecular imaging. In each of these applications, quantification of the photon fluence
and optical dosimetry is critical. Thus, the focus of this research is on the development
of image-based simulation tools to predict 3D photon distributions within optically
heterogeneous media and in the advancement of instrumentation to validate these
techniques. To accomplish these tasks, we propose to:

SA1: Develop, build and test an optical dosimetry probe and advance 3D Monte Carlo
photon transport code capable of measuring and simulating the local photon fluence
and dose in optical tissue phantoms;

SA2: Simulate and validate the absolute photon fluence in homogeneous and
heterogeneous brain tissue phantoms resembling white matter, gray matter, skull bone
and tumor;
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SA3: Devise an empirical model and algorithms capable of simulating for photon
propagation in complex heterogeneous tissues in real-time; and

SA4: Investigate the feasibility of using the above tools and methods to optimize optical
therapeutic protocols n human skull bones using image-guided techniques.

2.1

Specific Aim1: Develop, build and test an optical dosimetry probe and advance 3D
Monte Carlo photon transport code capable of measuring and simulating the local
photon fluence and dose in optical tissue phantoms

The rate and quantity of drug release depends on the optical fluence or laser energy
delivered to the tissues. To measure the photon fluence being delivered, we have
designed and calibrated an optical dosimetry probe to measure the localized (1mm3)
photon fluence in tissues with complex optical heterogeneities at depths in brain tissue
phantoms consistent with preclinical and clinical applications. Next, CUDA based 3D
Monte Carlo code was further developed to predictor of light fluence/energy
distribution in tissues. This software has been developed as an open source project by
the Dr. Fang’s group at Harvard. We have further modified this software package to
model and simulate 3D photon beams with Gaussian and super-Gaussian distributions
consistent with the laser beam in our laboratory, along with modifications to increase
the computation speed.
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2.2

Specific Aim2: Simulate and validate the absolute photon fluence in homogenous
and heterogeneous brain tissue phantoms resembling white matter, gray matter,
skull bone and tumor.

In order to be used as a therapy planning tool, the 3D Monte Carlo needs to be validated
in optical phantoms resembling white matter, gray matter and skull bone. The CUDA
based MC code was used to generate 3D photon fluence and energy absorption (or
dosimetry) maps generated and validated by optical dosimetry probe measurements in
homogeneous and heterogeneous brain tissue phantoms. Since the quantity and energy
threshold of drug released depends on the optical energy coupled to the tissues, the
cross validation of the dosimetry and simulation tools is a major step in ensuring
planning accuracy in clinical setting.

2.3

Specific Aim3: Devise an empirical model and algorithms capable of simulating for
photon propagation in complex heterogeneous tissues in real-time

Empirical models of photon transport provide an estimate of the local photon fluence in
heterogeneous tissues with fast execution times for the optimization of clinical
applications not afforded by Monte Carlo methods. The GPU based Monte Carlo
requires many hours of execution time to simulate photon distribution within a human
brain, which can be a disadvantage when optimizing a treatment plan iterating over
multiple illumination conditions. A weights-based empirical model approach to photon
propagation is investigated. It simulates photon scatter by using weights for directional
scatter of photons between neighboring voxels, and absorption using the Beer-
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Lambert’s law. These weights are determined using the Monte Carlo. The objective is to
achieve execution times on the order of seconds. Thus the empirical approach provides
an alternative means of evaluating multiple illumination conditions to reduce treatment
planning time before using the Monte Carlo for final validation of photon fluence and
provide real-time imaging corrections.

2.4

Specific Aim4: Investigate the feasibility of using the above tools and methods to
optimize optical therapeutic protocols in human skull bones using image-guided
techniques

While dosimetry and simulation studies using optical phantoms helps us measure of the
photon distribution in brain tissues under ideal conditions, it does not take into account
the heterogeneous composition of the skull bone and the bone-tissue interface, which
affects the optical transmission and distribution of photon fluence within the soft
tissues. Computed Tomographic images will be acquired to map the density and
composition of the bone along with the boundary conditions and to correlate and
predict the transmission of NIR light through the skull. Experiments will be performed
on human skull bone samples by mapping out the photon fluence transmitted through
the bone using the dosimetry probe and comparing it to the Monte Carlo simulated
photon distribution. Previous studies have indicated a wide variance in the optical
properties of the human skull bone, which can be accounted for by the Monte Carlo
code and optical dosimetry probe measurements developed in this research. Thus, the
best set of properties for the skull bone for each individual patient can be planned.
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3

SPECIFIC AIM1: OPTICAL SIMULATION AND DOSIMETRY TOOLS

3.1

Introduction

In order to estimate the amount of drug released in tissues, we need to be able to
derive the number of photons travelling in each voxel (also known as the “fluence”,
photons/mm2) and the photon energy absorbed per unit volume (mJ/mm3). The photon
fluence maps can be converted into their corresponding drug release maps by using a
threshold determined by in vitro studies. We modified a GPU based 3D Monte Carlo
(MC) to determine the photon fluence in tissues using different illumination beam
profiles. The validation of the MC software in tissue phantoms requires localized
measurements of photon fluence in tissue phantoms implementing an optical dosimetry
probe with isotropic acceptance. In this chapter, we describe the design, fabrication and
calibration of the probe and the validation of the Monte Carlo through its use.

3.1.1 Monte Carlo Algorithm
The Monte Carlo method generates a random number between 0 and 1 with a normal
distribution [57] to determine the step size and photon scatter direction based on the
optical properties of the medium [57, 59, 61, 64, 65].
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where the raw probability is P(r , t) at a position defined by r and at time t. Ea/Et is the
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In the above equation, #% is the absorption coefficient (mm-1) and #& is the scattering
coefficient (mm-1). The weight of the photon packet is absorbed within a voxel through
which it moves based on the pathlength [57, 59, 61]:
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The anisotropy factor g is the cosine of the phase function with values lying in between 1 to 1 [57], where g=1 indicates forward scatter, g=-1 implies back scatter, and g=0
means isotropic scatter. The unit vector directions in the x, y and z axis are as follows
[57]:
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(3.7)
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(3.9)

Where 
, 
x, y
z are the initial (pre-scatter) directional vectors in the x, y, z directions,
while  ,  ,  are the new or post-scatter directional vectors. Also the azimuthal

  !" # $% &'( )$!*+, $- ,.$$!+ )+!.tion and is given by [57]:
/ = 012

(3.10)

The Monte Carlo code takes the anisotropy factor along with the values of the index of
refraction, absorption and scattering coefficients as an input from the user to define the
optical properties of the medium. The photon energy deposited (or dose) (3456 in
photons or Joules) in each voxel is given by the product of the photon fluence (F(r7 , t) in
mm-2s or J mm-2s), the absorption coefficient (8 in mm-1), the photon pulse duration (or
illumination time) (9:;< in s) and the volume of the voxel (=>?@ in mm3):

3456 = F(r7 , t) 8 9:;< =>?@

(3.11)
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exposed to the TiO2-sphere [63, 68, 69]. This electrical voltage is then read using a
digital oscilloscope and integrated to obtain a quantifiable measure of the optical
fluence [63].

The radiant energy fluence rate at a position “r” is the integral of radiance ( , ) (units
Wsr-1m2) over all directions (defined by solid angle "") and is given by [68]:

(r) =  (, ) 

(3.12)

where the solid angle about the normal vector  is d .
The optimal construction of the dosimetry probe is such that the optical fiber is inserted
a predefined distance within the TiO2 sphere. This prevents a part of the light fluence
within the probe tip from entering the fiber, thus creating a “blind spot” [68]. This
requires a correction factor to be applied to the 4 sr solid angle acceptance of an ideal
dosimetry probe (without a blind spot). The blind spot can be defined in terms of the
solid angle

blind.

This correction actor Fb in a probe with fiber diameter d and diameter

D of the TiO2 sphere (with ""as the arbitrary angles of incidence) is given by [68]:
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Thus,
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(3.14)

The fluence passing through the fiber is measured by a flat PIN photodiode, whose
response Sflat is given by [68]:
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Similarly, for a dosimetry probe, infinitely small, the response to diffuse isotropic
fluence is given as [68]:

 =  0
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(3.16)

Thus in order to obtain the true fluence rate entering the probe, we multiply the
response of the PIN photodiode by a factor of 4, given by [68]:
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(3.17)

Similar to the blind-spot factor, a correction factor accounting for the difference in the
refractive index of the probe tip and the medium must be applied. The ratio of the
response of the dosimetry probe in liquids (Fn) relative to air has been studied and
measured extensively [68] and depends on the difference in the index of refraction
between the medium and the probe tip. The greater the difference in the refractive
indices causes a higher fraction of photons to be refracted back into the probe, and
higher sensitivity, compared to lower differences, e.g. TiO2-epoxy to air versus water.
The refractive index of the probe (solid) is well above the refractive index of water, thus
measurements in liquids with higher refractive index gives higher probe sensitivity.

Another potential correction factor, Fi, accounts for inhomogeneity in the construction
of the spherical probe tip resulting in an anisotropic response [68]. This factor accounts
for the angular variance in the probe’s response to different incidence angles in the
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equatorial and azimuthal directions. Excluding the extreme blind spot at oblique angles
(i.e. from the same direction as where the fiber enters the spherical bulb), the angular
variance of a well-constructed probe is generally low [63, 70]. In this study, the angular
response of the dosimetry probes to diffuse incidence fluence was measured to
determine its isotropicity of response. Thus the reading in air must be corrected to
obtain the true fluence rate ( ) using the following equation [68]:



3.2

=

   

(3.18)

Materials and Methods

3.2.1 Monte Carlo Beam Optimization
The original code of the GPU based 3D Monte Carlo (MC) (by the Fang group [61]) has
several built-in features to simulate photon sources such as Gaussian, flat beams, pencil
beams, isotropic point sources, cone beams, etc. The “open source” availability of this
software and functionality of using random numbers to generate and define photon
sources allows users to modify the original source code to add additional photon beam
profiles as used in different optical setups. The CUDA based parallel threading
functionality also improves the speed of simulation of broad beam sources compared to
the time consuming nature of simulating multiple pencil beams by calling Monte Carlo
function separately for each pencil beam. Even though we had used the process of
generating broad beam profiles, by calling the Monte Carlo serially, in our past studies
[60]; in this study we have optimized the Monte Carlo to generate broad beams by using
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the full functionality of the CUDA platform by generating individual pencil beams in
parallel.

In this study, we modified the original code to simulate a broad beam super-Gaussian
beam profile emanating from an optical fiberguide, coupled to the output of a LaserOPO system (Nd: YAG class 4 laser and a MagicPRISM Optical Parametric Oscillator from
Opotek Inc., Carlsbad, CA). This profile was measured with a calorimeter (gold standard)
(Ophir-Spiricon 3A-P-V1) with aperture 12mm, and can be represented with the
following equation:

   =

A

e



. ( )

(3.19)

where:
r = z tan (3.20)
In the above equations, A is the maximum or peak incident energy fluence (J/mm2), z is
the perpendicular distance from the source to a point along the central axis of the beam,

 is the divergence angle of the laser   is the standard deviation of the superGaussian lateral beam profile, n is the order of the super-Gaussian distribution. The
broad beam output of the fiberguide was approximated using multiple single sources
with super-Gaussian outputs. In our experimental setup, a match in beam profile was

   !"  #!$. The radius of the fiberguide source is 0.3cm. Besides the
super-Gaussian beam from the fiberguide, a flat broad beam with radius equal to the
output port of the integrating sphere (port radius 0.9cm) was used to characterize the
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output of the integrating sphere. The beam characteristics were measured using a
calorimeter (gold standard) and were given as input to the MC code to emulate the
illumination conditions used in the optical dosimetry setup.

We also added additional functionalities to the Monte Carlo to emit broad beam profiles
such as converging and diverging beams as emitted when light beams pass through
convex and concave lenses. This is of particular importance to researchers who wish to
explore the effect of different beam profiles on photon energy distribution in tissues.

In order to implement the simulation of converging and diverging beams, we allow the
user to select the beam parameters such as the aperture size (radius) and focal distance,
e.g., the real or virtual focal length for converging or diverging beams, respectively.

In order to simulate converging and diverging beams, we need to define the angle of the
photon source vector for each individual pencil beam. We define the emission angle 
for a beamlet as:


 =    (  ) (3.21)
where f is the focal depth and r is the radial distance from the center of the aperture of
the point source (or do you mean beamlet). The parameter r is selected randomly from
0 to R, where R is the radius of the source aperture. The angle of the photon beamlet
from this point within the aperture is (




). For a converging beam the initial photon
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vector is defined by –sin() and –cos() and for the diverging beam this vector is defined
by sin() and cos(  

            

.. The

photon vector directions are then calculated using equations 3.6, 3.7 and 3.8.

3.2.2 Optical Dosimetry Probe Design and Calibration
Two models optical dosimetry probes constructed with Nylon and Titanium Dioxide
spherical tips were fabricated and compared, specifically their sensitivity and
isotropicity of response.

The Nylon spheres have been widely used for photodynamic therapy and were made of
NylonTM due to their isotropic response [26]. These were used as the standard of
reference to compare the performance of Titanium based probes. TiO2 probes are
made from a mixture titanium dioxide (Du Pont Ti-Pure R-900) and a clear two-part
epoxy (Tra-Con BA-F114) in a ratio of 9.1 mg TiO2 to 1 ml of the epoxy [28, 29]. Titanium
dioxide was selected due to its particle size of around 410nm [28], which results in
optimal scattering at 820nm, the wavelength is approximately twice the particle size [28]
and in the center of the NIR spectrum (700-920nm). Since the wavelength used in our
studies is 800nm, the titanium probes have been designed to show a higher sensitivity
than the Nylon probes. The titanium based probe tips were fabricated using a specially
designed mold [70]. A fiber optic cable (BFL48-400, 4mm diameter, 0.48 numerical
aperture) was inserted within the cured spheres at a depth of approximately 1/3 of the
sphere’s radius [72]. The Nylon based probes were approximately 3.175mm diameter
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probe is mounted on and rotated by a rotary stepper motor, while keeping the same
central location of the probe. At each equatorial and azimuthal angle, the probe is
illuminated by a uniform broad beam of diffuse light formed by laser light (800 nm)
emanating from an integrating sphere (Melles Griot two port integrating sphere)and its
response, the output rms voltage, was measured at each angle. The isotropicity is
measured by calculating the coefficient of variation, the ratio of standard deviation to
mean of the rms value over all the angles. The range of angles was 0 to 360 degrees for
equatorial measurements, and 0 to 150 degrees for azimuthal. The angular span for
Azimuthal measurements was limited due to physical limitations of the setup which
prevented larger angles due to presence of the integrating sphere. The individual rms
voltage measured by the probe was normalized to the power measured using a
calorimeter.
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Note that the probe voltage signal was filtered using a bandpass Butterworth filter to
remove high frequency noise in the probe response. The photon fluence is proportional
to integral of the probe voltage output over the time of the laser pulsed. The probe’s
integral voltage as well as the calorimeter power was normalized to the exposed surface
areas of these detectors, where the probe (spherical) surface area is 7.065mm2 and the
calorimeter (circle) surface area of 113.04mm2.

The linear relationship in equation 3.19, used to quantify the photon dose in air, was
modified to account for the optical fluence in liquid brain phantoms. The light entering
the dosimetry probe depends on the ratio of the refractive index of the TiO2-expoxy
sphere to the medium. The refractive index of probe tip lies between the refractive
indices of titanium dioxide (approximately 2.73) [29] while that of the epoxy (around
1.53). Since the refractive index of air is smaller than that of water, the probe response
in water is smaller as more light will escape the probe when placed in water. The
reflectance factor is 0.41 for the probe-to-air interface (nprobe/nair is 2.5), and 0.74 for
the probe-to-water (nprobe/nwater is 1.88) [26]. The difference in the refractive index and
reflectance between probe-air and probe-water interfaces (water and tissue have
similar refractive index of 1.329) must be accounted for to quantify photon dose in
water. In order to determine the calibration factor, we measured the probe response in
air and water within a cuvette illuminated by a diffuse broad uniform beam emanating
from an integrating sphere (same setup as figure 3). The probe was placed inside the
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then measured again by fil   







), without changing the
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position of the probe with respect to the cuvette and the laser source. By accounting for
the water attenuation (μwater of 0.02cm1 and a path length of 0.2cm) and the difference
in the beam spread due to change in refractive index, the calibration factor (CF) was
determined experimentally to be 1.318, using the following equation:
CF =

 

 



(

!"#
)
!"

(3.23)

$%&

The difference in the beam spread difference between the cuvette-air setup versus the
cuvette-water setup is accounted for by multiplying the fluence measured in air with the
ratio of the measured beam spreads: fwhmair=40mm and fwhmwater=42mm, or a ratio of
0.9091.The experimentally derived calibration factor is then used for absolute photon
quantification by multiplying it to the probe response measured within tissues and
tissue-like media as follows (from equation 1 and 2):
'()*+,-./

w

 absolute

=

(012%334& )56.789:
;9<.=:

is the absolute dose in mW/mm2

(3.24)

> tissue

is the probe response

(mV/mm2), which is proportional to fluence measured in the tissue over the surface
area of the probe.
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3.3

Results

3.3.1 Monte Carlo Optimization
The Monte Carlo software was modified to simulate a super-Gaussian beam profile by
generated by laser light passing through an optical fiberguide. Figure 3.5 shows the
lateral fluence profiles generated by the MC and that measured by the calorimeter.
Modifications were also done to the original MCX software to simulate converging and
diverging beams, which are shown in figures 3.6 and 3.7. These were added for future
analysis of complex beam setups with lenses of specified focal length and numerical
aperture.

Figure 3.5 Super-Gaussian beam generated by the Monte Carlo, compared with the
optical fluence measured using a calorimeter [63].
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Figure 3.6 Images of converging, diverging and flat beams generated by the Monte Carlo.

Figure 3.7 shows an MC simulation of three convex lenses with different focal lengths
and with an aperture of 5mm. The increase in focal distance leads to a widening of the
focal spot in the z-direction as expected.

3.3.2 Optical Probe Calibration
The optical dosimetry probe was designed to quantify the localized fluence distribution
in tissues with a high degree of accuracy. This design was compared with standard
probes made from Nylon in order to analyze the advantages in linearity and anisotropy
of the novel probe model. The probe response was then characterized to quantify the
absolute photon fluence in tissues. This procedure involved the use of filtering to reduce
the statistical noise in the probe voltage and the determination of probe characteristics
in water (with tissue equivalent refractive index) versus those in air.
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Figure 3.8 Probe Isotropicity of Titanium v/s Nylon probes. The coefficient of variation
(standard deviation/average rms voltage) was calculated for probes made of Nylon and
Titanium. The error bars show the minimum and maximum values of variation in
individual probe response. The Titanium based probes showed a more isotropic
response in the equatorial and azimuthal directions. A 1.5mm diameter Titanium probe
was selected for further dosimetric studies.
Figure 3.9 shows the linearity of response of the 1.5mm Titanium based probe. The
probe response is linear over a dynamic range of 0.01074mW/mm2 to
0.031316mW/mm2 as measured by the calorimeter. The standard error (Standard

  

            

measuring multiple probe response in air over distances 10.1 to 18.1cm from the
fiberguide surface. The error in probe response is 1.695% (standard error = 0.226) and
the % error in calorimeter readings was 1.1299% (standard error = 0.00495). On the
other hand, the variation of the laser light emitted from the fiberguide over time was
approximately 3%. Thus the error due to variation in pulsed optical power of the laser
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was the major source of error in our measurements. These showed that Titanium
probes are better suited to optical dosimetry studies, as compared to Nylon probes, and
were used in brain phantom studies. While Nylon probes have been used before in
dosimetry studies, this is the first time that titanium probes were designed with a better
isotropic response.

Figure 3.9 Probe linearity: graph of total voltage (area under pulse) (mV/mm2) measured
by a 1.5mm diameter Titanium probe versus the power measured by a calorimeter per
unit surface area (mW/mm2). The probe response is linear over a dynamic range of
1.2mW to 3.5mW as measured by the calorimeter. The error bars represent 3%
variation in pulsed laser power fluctuation measured by the probe and calorimeter.

The filtering of the probe response reduces the noise in the probe voltage and provides
a clean signal. The Butterworth filter used can be tuned to optimize the signal to noise
ratio and removes the high frequency noise in the probe voltage, mainly attributed to
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electronic noise externally induced in the PIN photodiode circuit. The use of the filtered
signal also reduces the noise dependency of the measured fluence as we saw that the
noise variations in the measured signal mainly affected the measured output in the low
fluence regions, where (S/N) ratio is low. The filtering step (final versus initial signal) is
shown in figure 3.10. It is clearly seen that the high frequency noise at the periphery of
the signal is reduced. This can be even reduced further by adjusting the filter
coefficients, based on the operator’s discretion.

In order to quantify the measured probe voltage, there are several methods which can
be used. Some commonly measured parameters are the root mean square (RMS)
voltage, mean voltage and maximum voltage. In our studies we found that the RMS
voltage is a reliable parameter can be used to quantify the signal. However the RMS
voltage also depends on the signal noise and can be problematic if the noise level
changes with photon fluence measured. Thus in order to quantify the photon fluence,
we used the integral of the voltage (or area under the peak) of the measured signal. This
quantity can be made independent of the noise level by summing only those voltages
above a certain noise threshold level. In our studies, we found that a threshold of 5% of
the maximum value of the measured voltage was sufficiently above the average noise
variations at the signal periphery. Thus, while RMS value is a quick means to estimate
the measured fluence, the area under the peak can be a better measure of the absolute
photon fluence, provided all the necessary calibration factors are calculated.
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Figure 3.10 Filtering the response using a Butterworth band-pass filter. The signal to
noise ratio is significantly improved by using the filter.

In order to calculate the absolute photon fluence in tissues and tissue-like media, the
probe voltage measured within the medium must be multiplied by the calibration factor
to account for the change in photon loss in the probe-medium interface with respect to
the probe-air interface, where the calibration was performed. Since the refractive index
of tissues is nearly same as that of water, the calibration factor obtained for water can
be used for biological media. The probe calibration factor was determined to be 1.32.
The technique presented (using equations 3.22, 3.23, 3.24) provides a simple method to
determine the calibration factor experimentally, and is a novel addition to our research.
It is important to note that while equation 3.23 remains same for any probe, the
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equations 3.22 needs to experimentally determined, so as to derive equation 3.24 for
absolute photon dose quantification.

3.4

Discussion

The Monte Carlo code was optimized to emit a super-Gaussian beam profile. Its voxel
based design allows us to clearly define object boundaries and specific optical
properties of each voxel in the volume to be simulated, generating a photon fluence
(units: J.mm-2.s-1 or photons.mm-2.s-1) \ and an absorbed energy (units Joules) map. The
latter is calculated by multiplying the simulated fluence (J.mm-2.s-1) with the absorption
coefficient (units mm-1) of the voxel, volume (units: mm3) of the voxel and the length of
the time period (units: seconds). The 3D voxelated output of the Monte Carlo is can be
conveniently integrated and analyzed with 3D medical imaging modalities such CT, MR,
Ultrasound, etc. Thus absolute photon quantification using Monte Carlo has the
potential to be used for image guided therapy. The reduction in simulation times
(couple of hours) of the CUDA based Monte Carlo also improves its potential to be
applied in the clinic for calculating the photon dose in optical based therapies.

We designed an optical dosimetry probe with a linear and isotropic response, and with
superior sensitivity compared to Nylon probes. These dosimetry probes can now be
used for in vitro and in vivo studies for localized measurement of the absolute photon
fluence. The calibration of the dosimetry probes allows us to measure its linearity and
isotropicity and derive the calibration factors necessary to measure the absolute energy
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fluence in mW/mm2. The calibration factor (1.32) derived in this study accounts for the
difference in the sensitivity of the probe in air and water. The other calibration factor is
the isotropic sensitivity of the probe and depends on the probe orientation. This factor
gives the % error in probe response based on the azimuthal and equatorial orientation
of the probe. An average error over all the angles is sufficient to understand the
variations in measurement based on probe orientation, with the goal of having each
measurement independent of the probe’s absolute position in the media. More studies
using goniometric measurements may improve the accuracy of the measurements and
are recommended before using the probe in a clinical setting. Our study has shown the
advantages of using Titanium Dioxide probe over traditional probes made of Nylon for
dosimetry studies for NIR wavelengths of around 800nm. More dosimetry probe
materials can also be researched for better sensitivity at larger infra-red wavelengths if
necessary.
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4

SPECIFIC AIM2: VALIDATION OF MONTE CARLO IN TISSUE PHANTOMS

4.1

Introduction

In order to be used as a therapeutic tool, the Monte Carlo software needs to be
validated. The Titanium Dioxide based optical dosimetry probe, described in the
previous chapter, allows us to accurately measure photon fluence distribution with
millimeter resolution, high sensitivity, and negligible orientation dependencies, ,
compared to previous Nylon-based dosimetry probes. In this chapter we describe the
design of accurate tissue phantoms of white matter, gray matter, and skull bone used to
validate the Monte Carlo generated photon fluence. In all these studies, the optical
dosimetry probe serves as a gold standard photon energy fluence and its uncertainty..

4.1.1 Optical Phantom Characteristics
The design of optical phantoms requires an accurate and precise measure of the
absorption coefficient (µ a
coefficient µ s1
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factor (g) and refractive index (n), at a

     

    

    



matter. Since tissues are made of molecules which scatter and absorb photons, an optical
tissue phantom is composed of a combination of scattering (e.g. Intralipid, Titanium
dioxide, Aluminum Oxide, Polymer Microspheres, Quartz Glass Microspheres) and
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absorbing materials (e.g. India Ink, Molecular dyes such as Indocyanine Green (ICG),
Fluorophores), each in varying proportion based on their individual absorption and
scattering properties [73-77]. These absorbers and scatterers are added to water or agar,
which provides a stabilizing medium for uniform distribution of the absorber and
scatterer molecules, and defines the refractive index of the resulting phantom. An optical
phantom should be designed such that its optical properties closely match those of the
corresponding tissue at the wavelength of interest. This however is a complex problem
due to the apparent mismatch between “non-absorption” related properties (µ s
absorbers and “non-scattering” related properties (µ a


      

    



   



One way to reduce this complexity is to select materials that

have closely matching g and n values to tissue (water and agar), a pure scattering media
with negligible absorption properties, and a pure absorber with negligible scattering
properties, while allowing uniform mixing of absorber and scatterer molecules [73].

4.1.2 Spectro-photometer Calibration
In this study, intralipid was used as a scatter and India ink as an absorber in
concentrations that resemble the optical properties of white matter, gray matter and skull
bone. For each tissue type used in the brain phantom, the absorption coefficient of India
ink and scattering coefficient of intralipid were determined using a spectro-photometer
which served as the gold standard to measure absorption and scattering properties. While
absorption properties of India ink (units: %Concentration-1cm-1) vary from batch to batch
in commercially available samples, the variation in the scattering properties
(units: %Concentration-1cm-1) of Intralipid are less across different samples. This is
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For a purely absorbing medium the absorbance measured by the spectrophotometer is
related to the absorption coefficient of the medium by:

 ()
 ( ) =  () (4.2)
where “loge” is the natural logarithm. Similarly the scattering coefficient of a medium
with a low concentration of scatterers can also be derived from the absorbance
measurement of the spectro-photometer:

 ()
 ( ) =  () (4.3)

Equation 4.3 is true only if the transmitted light intensity is collimated, does not
undergo multiple scattering events and if the detector aperture is very small [76]. This
places restrictions on the range of concentrations across which the scattering properties
can be measured using the spectro-photometer. In this study we validated the
scattering properties of the intralipid medium across extremely low concentrations
using probe measurements as well as by comparing to past studies. Past studies by Van
Staveren [76] have measured the optical properties of intralipid, which can be derived
using the equations [76]:
.

(4.4)

g( ) = 1.1  0.

(4.5)

 ( ) = 0.016
and

where is in micrometers (0.4< <1.1) and the scattering coefficient  ( ) is in mL.L.mm-1. This yields an anisotropy factor of g( ) = 0.636 and a reduced scattering

1
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coefficient of 9.95 (%Concentration)-1.cm-1 at  = 800 nm. In this study we have used the
anisotropy factor derived from equation 4.5 and will compare the scattering properties
of intralipid to those obtained through equation 4.4.

4.1.3 Probe and Monte Carlo based validation of intralipid
To further verify the optical properties of intralipid solutions, we did another study using
the dosimetry probe to measure the extinction coefficient of intralipid solutions. The
extinction coefficient derived by the probe measurements were then matched by the
Monte Carlo. The corresponding scattering coefficients which showed the best match to
data were selected as the true values for that concentration. This additional study cross
validates the spectro-photometer studies [76] shown by equation 4.4. The reasoning
behind this study was to be absolutely sure that the scattering coefficient per unit
volume of the 20% intralipid samples used in our studies were of the same property as
the 10% intralipid samples used by the Van Staveren study.

4.2

Materials and Methods

4.2.1 Characterization of Optical Phantoms
Optical brain phantoms were designed to emulate the absorption and reduced scattering
coefficients of white matter, gray matter and skull bone at 800nm [79, 80]. Previous
studies have shown that reliable optical phantoms can be built using India ink (absorber)
and intralipid (scatterer) [74 – 77] , in addition to the optical absorption by water
mol   a = 0.02cm1) [81].
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The absorption coefficient of India ink (Higgins non water proof black ink) and the
scattering coefficient of intralipid (Intralipid 20% from Fresenius Kabi), at 800nm
wavelength, was determined and validated using a spectro-photometer (Shimadzu
UVmini 1240 Spectrophotometer), which served as the gold standard to measure
absorbance. The scattering properties of intralipid can be determined using the
spectrophotometer for low concentrations and was found to have the average value of
9.524 cm1 %Concentration1, compared to 9.95 cm1 %Concentration1 as shown in past
studies by Van Staveren [76]. Figures 4.2 and 4.3 show the calibration curves of the
absorbance versus concentration of India ink and Intralipid, and the linear fit was used to
design optical phantoms that resemble white matter, gray matter and skull bone, similar
to Van der Zee [79] and Firbank [80]. In Tables 4.1 and 4.2, the measured ex vivo optical
properties (absorption and scattering coefficients and anisotropy factor) of skull bone,
gray and white matters and those used in our research studies are shown (the latter
derived from figures 4.2 and 4.3).
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phantoms comprised of layers of 1% agar doped with India ink and intralipid to
represent skull bone and gray matter, and topped with a solution of white matter. The
agar phantom preparation involved boiling a solution of India ink (with predetermined
concentration) and 1% agar (Fisher Scientific Laboratory Grade Agar A3600-500) in a
microwave at 95 degree Celsius and adding intralipid to the solution after being stirred
and cooled to below 45 degrees Celsius. The scattering properties of agar and
absorption properties of India ink were also measured using a spectrophotometer for
each individual sample used in the study, while the scattering properties of intralipid
were derived from the linear relationship in figure 4.3.

Table 4.1 Optical Properties of Brain Tissues [79, 80]
Tissue
Type

White
Matter
Gray
Matter
Skull
Bone

Absorption

Anisotropy
Factor (g)

(cm-1)

Scattering
Coefficient
 s) (cm-1)

0.05

550

0.85

Reduced
Scattering
Coefficient
 s) (cm-1)
82.5

0.35

700

0.965

24.5

0.24

184

0.9

18.4

  a)
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Phantom
Type
Liquid
Phantom
Liquid
Phantom
Liquid
Phantom
Solid
Phantom
Solid
Phantom

Table 4.2 Phantom Composition [63]
Tissue
Intra Ink %
Absorption Scattering
Coefficient Coefficient
Type
lipid
-1
-1
%
a) (cm )
s) (cm )
White
7.5
0
0.002
197.352
Matter
Gray
2.36 0.023 0.3792
62.187
Matter
Skull
1.82 0.0156 0.26
47.922
Bone
Gray
2.56 0.0195 0.35
67.308
Matter
Skull
1.92 0.0134 0.25
50.549
Bone

Anisotropy
Factor (g)
0.636
0.636
0.636
0.636
0.636

4.2.2 Validation of 3D Monte Carlo in brain phantoms using Optical dosimetry
As described in the previous section, liquid optical phantoms, resembling white matter,
gray matter and skull bone, were designed using predetermined concentrations of India
ink and Intralipid. The setup for the light dosimetry in the phantoms is shown in figure
4.4. Two sources of NIR light (an integrating sphere and an optical fiberguide) were used
to illuminate the phantoms, both of which were connected to the laser source (same
specifications as used in the calibration process). The dosimetry probe was inserted into
the phantom and translated using a 3D translation micrometer stage and used to
measure the optical fluence distribution at various x, y and z locations within the
phantom. The x, y and z fluence distribution generated by the Monte Carlo was
compared to the probe measurements to the test the validity and accuracy of the
Monte Carlo code. The percentage match of the Monte Carlo was calculated relative to
the probe measurements to estimate the level of confidence of fluence estimation. The %
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difference between the probe measured fluence and the Monte Carlo was calculated
both along and perpendicular to the beam axis.

Figure 4.4 Setup for Optical dosimetry in a liquid phantom. The optical dosimetry probe
is translated within a plexiglas cuvette filled with liquid phantom, and illuminated by an
NIR source.
In order to quantify the photon fluence (

 ) in J/cm2, we converted the output of

the Monte Carlo fluence (, photons/mm2) as follows:

  =   (4.6)
where h is Planck’s constant (6.626e         
light in the medium. The energy deposited in the tissue is obtained by multiplying the
photon fluence with the absorption coefficient μa and the volume of the voxel (v):

!" #"$ =   %! v

(4.7)
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4.3

Results

4.3.1 Optical Dosimetry and Monte Carlo Validation in Homogeneous Phantoms
The optical fluence measured by the dosimetry probe in white and gray matter phantoms
was compared to the Monte Carlo generated fluence. The design of optical phantoms is
crucial for accurately determining the localized distribution of fluence with the probe
before validating it using Monte Carlo. Figures 4.5 and 4.6 show the comparison between
the probe measurements and the Monte Carlo in brain phantoms for two different
illumination profiles, the flat diffuse beam produced by the integrating sphere and the
super-Gaussian beam emanating from the optical fiberguide. Comparisons were made
along the central axis of the beam and in the direction perpendicular to the beam axis at
different depths, as shown in figure 4.7. These plots reveal the energy fluence measured
by the probe matched Monte Carlo simulations both along and perpendicular to the beam
direction.
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Figure 4.5 Optical dosimetry in white and gray matter phantoms. The photon source
used is an integrating sphere connected to a pulsating laser source. The graphs show the
exponential decrease of photon fluence along the beam axis in white and gray matter
mimicking phantoms. The Monte Carlo generated fluence closely matches the fluence
measured by the probe.
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Figure 4.6 Optical dosimetry in white matter, gray matter and skull bone phantoms. The
photon source used is an optical fiberguide (connected to a pulsating laser source) with
a super-Gaussian beam distribution. The Monte Carlo generated fluence closely
matches the fluence measured by the probe. This shows that the Monte Carlo beam
modeling can be reliably used as a reliable estimator of photon energy distribution in
tissue phantoms.
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A

B

Figure 4.7 Lateral beam profile measurement using optical dosimetry probe and
validation by Monte Carlo in homogeneous phantoms. (A) Beam profile in air using
calorimeter. Optical dosimetry measurements validated MC simulated lateral beam
profiles in phantoms of: (B) white matter, (C) gray matter and (D) skull bone, i.e.,
perpendicular to the beam axis. The measurements were normalized along the
illumination axis. Cuvette dimensions: 5.3cm x 4.6cm x 3.1cm, thickness = 0.4cm.
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C

D

Figure 4.8 Continued
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The average relative % error of the Monte Carlo relative to the probe measurements is
11.27% for white matter, 13.25% for gray matter and 11.81% for skull bone along the
beam axis for a range of 0.2-2cm within the phantom, while perpendicular to the beam
axis, the % relative error is 9.4%, 12.06%, and 8.91% for white matter, gray matter and
skull bone phantoms. These systematic errors represent the levels of confidence with
which the Monte Carlo matches the probe measurements, see tables 4.3 and 4.4.

Table 4.3 % Mismatch Error in Homogeneous Phantom along beam axis (z)
Phantom Error%
(0.2-1 cm)
White
12.13
Matter

Error%
(1-2 cm)
10.5

Average
error%
11.27

Gray
Matter

13.39

30.12

13.25

Skull
Bone

11.39

12.28

11.81
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Table 4.4 % Mismatch Error in Homogeneous Phantom perpendicular to beam axis (z)
Phantom

Error%
z=0.2cm

Error%
z=0.6cm

Error%
z=1.0cm

Error%
z=1.4cm

Average
error%

10.34

13.34

9.14

4.79

9.4

Error%
z=0.2cm

Error%
z=0.4cm

Error%
z=0.6cm

Error%
z=1cm

Average
error%

13.45

11.52

14.29

8.97

12.06

Error%
z=0.6cm

Error%
z=0.7cm

Error%
z=0.8cm

Average
error%

8.41

5.69

12.64

8.91

White Matter

Phantom
Gray Matter

Phantom
Skull Bone

An analysis of the fluence profile within the skull phantom showed that the superGaussian beam fluence decreases with an effective attenuation coefficient of 4.818cm-1.
This factor was used to estimate the effectiveness of therapy for different skull
thicknesses. Based on the validated Monte Carlo method, the power transmitted by the
fiberguide source for various skull thicknesses are 5.9mW/cm2 (0.4cm thick),
2.16mW/cm2 (0.6cm thick), 0.83mW/cm2 (0.8cm thick), 0.33mW/cm2 (1cm thick). Thus,
the % power transmitted in a 1cm thick adult skull is 1.8%, while a pediatric skull of
0.4cm thickness would allow 33.5% optical power to reach the soft tissue. The thickness
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of the skull and its density determines the overall attenuation and hence optical
planning protocols which can be obtain from a CT scan (see chapter 6).

4.3.2 Optical Dosimetry and Monte Carlo Validation in Heterogeneous Brain Phantoms
Fluence profiles measured in the white matter solution in the layered heterogeneous
phantom (1.1 cm skull agar phantom, 1.1 cm gray matter agar phantom, 5.9 cm white
matter liquid phantom in the said order), showed a good degree of match between the
Monte Carlo simulated data and the probe measurements, see figure 4.8. The
exponential decrease in fluence along the beam axis is shown on the right side of figure
4.8 while the lateral beam profiles at different depths above the gray matter agar
surface is shown on the left side of this figure. The lateral fluence profiles have been
normalized to the intensity at a depth of 0.2cm above the gray matter agar surface,
while the fluence profiles along the beam axis were normalized to the fluence at z =
0.1cm above the gray matter agar surface. The average systematic error (relative %
error) between the probe and Monte Carlo fluences is 17.71% along beam axis and
18.04% perpendicular to the beam axis and is shown in tables 4.5 and 4.6. The validation
of optical dosimetry results in the complex layered phantom validate that the beam
spread can be estimated correctly by the Monte Carlo if the optical coefficients of the
phantom are known.
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Figure 4.9 Validation of Monte Carlo in a heterogeneous phantom (1.1cm skull agar,
1.1cm gray matter agar and 5.9cm white matter liquid). Lateral profile measurements
(in the white matter phantom solution) are shown on the left while axial comparison is
on the right. The depth shown by z is the distance from the gray matter agar surface.
Cuvette dimensions: 9.4cm x 9.4cm x 10.9cm, thickness = 0.3cm.
Table 4.5 % Mismatch Error in Heterogeneous Phantom along beam axis (z)
Phantom

Error%
(0.1-1 cm)

Error%
(1-2 cm)

Average
error%

2.11

33.32

17.71

White Matter (over Skull and
Gray Matter layers)

Table 4.6 % Mismatch Error in Heterogeneous Phantom perpendicular to beam axis (z)
Phantom
White Matter (over Skull
and Gray Matter layers)

Error% Error% Error%
z=0.2cm z=0.4cm z=0.6cm

Error% Average
z=1cm error%

18.52

23.17

15.09

15.37

18.04
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4.4

Discussion

We validated the 3D Monte Carlo code using the TiO2 based dosimetry probe
measurements in phantoms resembling white matter, gray matter and skull bone. When
comparing absolute fluence measurements, the error between MC simulated data and
measured data was less than 25 percent within these homogeneous tissues. The
independent characterization of the probes and the optical phantoms using calorimeter
gold standard and spectrophotometer demonstrated the validity of using the probe as a
gold standard. Studies were performed for two different types of NIR light sources in
different optical phantoms, and the ease of photon quantification to absolute dose (in
mW/mm2 or J/mm2) proves the fidelity of the Monte Carlo as a predictive tool to
accurately estimate 3D photon energy distribution in complex media. The measurement
and prediction accuracy can be improved with better instrumentation for probe
localization and better laser beam positioning setups. The boundary conditions of the
phantom play a very important role in the Monte Carlo results and need to be simulated
accurately. This includes the accurate depiction of cuvette/phantom dimensions,
distance from the source and source dimensions.

This study achieves the first step of designing the tools necessary to validate the NIR
photon distribution in three dimensions in optical phantoms. By quantifying the energy
fluence and local deposited dose will allow an accurate depiction of the rate and
quantity of drug release. Critical to these simulations is the accurate determination of
the tissue structure and boundaries, which can be determined using imaging modalities
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such as MRI or CT scan to segment various tissue types and obtain an optical property
map. This can now be seamlessly input into the Monte Carlo under various illumination
conditions.
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5

SPECIFIC AIM3: EMPIRICAL APPROACH TO PHOTON PROPAGATION

5.1

Introduction

Translating an optical planning tool into the clinic requires simulations to be performed
in time frames that are feasible. Monte Carlo simulations takes a few hours of execution
time to generate statistically significant number of photons for full brain, and this is for a
single laser source. Obtaining an optimal optical treatment plan requires dose
calculations for multiple laser sources and iterations to ensure maximal light delivery to
the target tissues. Hence, even though the CUDA based platform enhances the speed of
the Monte Carlo by 300X over CPU based models [61], it still would need to be
significantly accelerated to be provide treatment plans in a clinical setting. This can be
accomplished by purchasing a cluster of NVIDEA cards (costly). Instead, this motivated
us to design an empirical model approach to estimate photon propagation in complex
heterogeneous tissues, which could have a runtime of less than a minute while
providing a reasonable level of accuracy [64].

A number of analytical solutions are made to the radiative transport equation, also
known as the Boltzmann transport equation [82]:

. 

(r, ) +



(r) +  (r) (r, ) = S(r, ) +  (r)



(r, ) p(, )d (5.1)
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In the above equation, S(r, ) is source term and describes the power injected into a
solid angle defined by  within a unit volume at position r;  is the photon propagation
unit vector; (r, ) is the radiance energy (units: W.cm2.sr1); r is position vector;
p(, ) is the phase function and represents the probability of photon scattered from
direction  to .

The fluence, (r), is obtained by summing the energy radiance, (r, ), over all
directions [82]:

(r) =  

(r, )  . (5.2)

Solving the radiative transport equation can be solved using finite difference methods
under certain approximations [82]. One such method is the DANTSYS (diffusion
accelerated neutral particle transport code system) [82].

The diffusion approximation (P1 approximation) is the most commonly used analytical
approximation to the radiation and is used widely to calculate fluence in homogeneous
and heterogeneous tissues and is given by the equation [82, 83]:




( ,)

+  (r, t)  . [D(r, t)] = S(r, t). (5.3)

The diffusion equation can thus be used to derive the optical fluence in homogeneous
and heterogeneous tissues by using diffusion synthetic acceleration method (DANTSYS)
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and employs a corrected diffusion equation to accelerate the convergence of transport
iterations. The use of the diffusion equation results in under-estimation of fluence in
media with a high ratio of absorption to scattering coefficients [82, 84]. The Monte Carlo
method thus remains the only method to accurately simulate photon fluence over a
wide range of albedos.

In our study, we investigated a voxel-based, nearest neighbor weight based method
trained using Monte Carlo simulated data. In retrospect, this approach is similar to the
photon convolution method [85], but uses arbitrary weights to determine photon
scatter at each location (voxel) in a 3D volume. The absorption of photons in each voxel
is determined using the Beer Lambert’s law [78] and the optical absorption coefficient.
The photon dose distribution is simulated in a 3D voxelated format for easy comparison
and 3D optimization with the Monte Carlo and allows seamless integration with medical
imaging modalities such CT and MR, used to characterize tissue heterogeneity and
object boundaries of the medium. The empirical nature of this software can be easily
adapted to different optical properties and voxel sizes by adjusting the scattering
weights, while the absorption coefficient remains unchanged. As with the MC code,
different beam profiles and upstream optics can be seamlessly integrated to improve its
applicability. Realization into CUDA can provide corrective algorithms on the order of a
few seconds and real-time applications.
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5.2

Materials and Methods

5.2.1 Algorithm Design
The Empirical approach is based on the assumption that the photon fluence in a voxel in
a particular layer is a weighted sum of the fluences of neighboring voxels in the previous
layer [63, 64]. The basic concept and schematic of this algorithm is illustrated in figures
5.1-5.3. The steps of the algorithm can be summarized as follows:
1. Assign the incident photon beam distribution (e.g. super-Gaussian beam) to the first
layer of voxels. In this case, we assume that the direction of photon propagation is in
the +z direction.
2. For every voxel in a layer, calculate the directional scatter components. The
equation 8 represents an example of how the forward scatter component is
calculated. The coordinates i, j, k denote the x, y and z location of the voxel. The
arbitrary weights wt1 and wt2 are forward and diagonal weights, which determine
the percentage of scatter. The sum of all weights is always equal to one (i.e.
wt1+4*wt2=1), so that the total fluence entering a voxel is equal to the sum of
fluence absorbed and exiting the voxel. The equations used to calculate the other
components can be similarly determined. The sum of all the scatter components in a
voxel equals the total fluence in that voxel (arbitrary units: photons/unit volume).
3. Calculate absorbed energy (Iabs) using Beer Lambert’s law for a path length dl = voxel
length, based on the absorption coefficient (μa) of the voxel:


 (i, j, k)

= I(i, j, k)(1

   )

(5.4)
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4. Calculate and accumulate the fluence over all voxels in the current layer and
increment z to proceed to the next layer. Continue propagation till the fluence exits
the volume.

An example of the implementation of this algorithm in 3D matrices using nested “for
loops” is shown in figure 5.3 (A). The purpose of this flowchart is to explain the details of
the algorithm from the perspective of its implementation. Different iterating loops and
several different data structures are possible to implement this algorithm based on the
memory and performance requirements.

We implemented an iterative routine, shown in figure 5.3 (B), in order to ensure that
residual fluences exit the 3D volume. The rationale behind this step is that some sidescatter and back-scatter components are significantly high in media with high scattering
coefficients (e.g. white matter). While the software is implemented in the form of a
primarily forward propagation direction, it leaves behind residual fluence components
which do not contribute to the total fluence and which do not exit the volume. Thus in
order to ensure that all residual photons leave the volume, we implemented an iterative
routine to propagate photons in the forward (+z) and reverse (-z) directions alternatively.
This was implemented in an iterative fashion. In the first iteration we propagate the
photons in the +z direction while in the next iteration the matrices are flipped (along the
x, y, z planes) such that +z direction now refers to the –z, +x refers to the –y and +x
refers to the –x directions. In other words the matrix is turned upside down. The
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empirical code is run again (without any additional input fluence) such that the iteration
is mainly in a direction opposite to the first iteration. We again flip the matrix to its
original orientation before running the empirical iteration. This is continued until we
ensure that most photons have exited the volume and the residual fluences are below a
certain threshold. In our study we found that 14 iterations were sufficient to ensure that
most photons have exited the volume. It is important to note that the iterative routine
mainly ensures a better match with Monte Carlo in the lateral direction (in xy plane)
away from the beam axis. The number of iterations has less effect on effective
attenuation at the center of the beam where most of the fluence is contributed to by
the forward directional fluence vector.

Figure 5.1 The Empirical photon propagation [64]: The photons in a voxel is propagated
to neighboring voxels using scatter weights.
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Figure 5.2 Integral or accumulation of fluence in a voxel. [64]. The dorectioonal fluences
such as forward (If), diagonal upwards (Id), diagonal downwards (Idb) and side (Is),
eneterig a voxel are weighted and summed using forward (wt1) and diagonal weights
(wt2). Fluence is redistribution conserved by ensuring that (wt1 + 4 x wt2) = 1.
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scaled to the voxel size and the photons are absorbed before proceeding to the next
layer.

5.3

Results

5.3.1 Empirical Optimization results
In this section we describe the optimization studies performed on the Empirical
algorithm. Both these studies were performed separately for brain tissues and tissue
phantoms, mainly due to the difference in their optical anisotropy factors, which leads
to subtle changes in fluence distributions. Table 5.1 shows the weights derived for brain
tissue phantoms (composed of India ink and Intralipid), while table 5.2 shows the
weights for real brain tissues. The optical properties of brain tissues are shown in table
4.1 while those of the tissue phantoms are shown in table 4.2. The corresponding
comparison in fluence profiles along the beam axis is shown by figure 5.4 for brain tissue
phantoms and by figure 5.5 for real brain tissues. The difference in the properties mainly
arises from the difference in the anisotropy factor between intralipid and the brain
tissues. Thus while we have achieved a match in the reduced scattering coefficient
between the phantoms and the real tissues, the photon distribution varies to some
extent between tissues and phantoms, as seen by Monte Carlo simulations. Hence we
trained the Empirical algorithm to match the match the Monte Carlo generated fluence
separately for both brain tissues and tissue phantoms. The different resultant weights
derived between phantoms and tissues also validates the purpose.
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We also did a comparison of lateral fluence profiles generated by the Monte Carlo and
the Empirical and these are shown in figures 5.6 -5.9. While the optimization routine
used the match in fluence attenuation along the beam axis as the main criteria, we tried
to see if this translates into a match along the lateral direction at different depths
(z=2mm, z=5mm, z=10mm, z=15mm) in homogeneous tissues. Our analysis shows that
the lateral profiles of the Empirical algorithm closely match those of the Monte Carlo
under similar illumination and boundary conditions.

Table 5.1 Weights derived for Brain Tissue Phantoms [63]
Tissue

Voxel Size

Wt1

Wt2

R-square

Phantom

(mm)

White Matter

0.1

0.949461

0.012635

0. 99999

Gray Matter

0.1

0.87469

0.031328

0. 999969

Skull Bone

0.1

0.914828

0.021293

0. 99979

White Matter

1

0.474876

0.131281

0. 99992

Gray Matter

1

0.062097

0.234476

0.999828

Skull Bone

1

0.245949

0.188513

0. 999871
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Figure 5.10 shows the comparison between the Monte Carlo, Empirical and Probe
measurements in brain tissues for broad beam simulations in homogeneous phantoms.
The weights derived for tissue phantoms are different from tissues. For the tissue
phantoms, the weights used are from table 5.1. The beam simulated in a super-Gaussian
beam as described in chapter 4. The super-Gaussian beam can be easily simulated using
the Empirical as it allows us to set the photon distribution at any voxel. The average
relative % error between the Empirical and Probe measurements is 10.2% for White
Matter, 45.2% for Gray Matter and 22.1% for Skull Bone phantoms; while the
comparison between Empirical and MC is 22.6% for White Matter, 35.8% for Gray
Matter and 21.9% for Skull Bone phantoms. The probe measurements validate the
Empirical results and the Monte Carlo in homogeneous phantoms.
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Figure 5.11 Comparison of the Empirical algorithm with Monte Carlo and Probe
measured fluence in brain phantoms resembling white matter, gray matter and skull
bone. The illumination source used is a super-Gaussian beam, which is emulated by the
Monte Carlo and the Empirical algorithm. The empirical approach is a close
approximation of the Monte Carlo and the probe over the range of optical properties of
brain tissues. [63].

5.3.3 Simulations in Head Phantoms
We simulated head phantoms to compare the Monte Carlo and Empirical fluence and
energy distributions. The phantom simulated had the dimensions of a child’s head. The
simulation studies were done in the presence (figures 5.11 - 5.14) and absence (figures
5.15 – 5.18) of tumor to study how well the Empirical photon distribution matches the
Monte Carlo. 2D photon energy maps were also generated and compared. The weights
used for the simulations were those of real brain tissues as shown in table 5.2. While the
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Monte Carlo only generates the fluence map, the energy map is derived from the
fluence map by multiplying the fluence with the absorption coefficient and the volume
of the voxel.

In the case of the normal head phantom (without tumor) of 100mm diameter, the
boundary conditions and tissue dimensions are shown in figure 5.11. The skull thickness
is 4mm; thickness of gray matter is 10mm, while the center of the head is mainly white
matter with a diameter of 72mm. The phantom is illuminated with a 20mm diameter
uniform beam (800nm wavelength). Figure 5.12 shows the comparison plot of the
energy deposition between the Monte Carlo and the Empirical along the beam axis. The
first point on the plot starts at the point where the light enters the skull tissue (i.e.
depth=0 in the plot of figure 5.12 corresponds to z=6 along the beam axis in figure 5.11).
Similarly, figure 5.13 shows the log normalized fluence plot along the beam axis. Both
the fluence and the energy plots show that the Empirical fluence and energy simulated
closely follow those of the Monte Carlo within a certain error. The energy distribution
maps in 2D are shown in figure 5.14. Note that the Monte Carlo generated map suffers
from extremely low photon fluence at depths larger than 5cm due to low photon
statistics (restrained by the time for head simulations), while the Empirical algorithm
does not suffer from this limitation.

We also studied the performance of the Empirical algorithm in a head phantom in the
presence of a tumor (astrocytoma) of 5mm diameter. The boundary conditions of other
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Figure 5.13 Comparison of photon energy distribution between the Empirical algorithm
and Monte Carlo in a head phantom, along the beam axis. The illumination source used
is a uniform beam of 2cm diameter. The plot is from the point where light enters the
skull bone (refer to figure 5.11).
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Figure 5.14 Comparison of photon fluence distribution between the Empirical algorithm
and Monte Carlo in a head phantom, along the beam axis. The illumination source used
is a uniform beam of 2cm diameter. The plot is from the point where light enters the
skull bone (refer to figure 5.11).
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Figure 5.18 Comparison of photon fluence distribution between the Empirical algorithm
and Monte Carlo in a head phantom with tumor, along the beam axis. The illumination
source used is a uniform beam of 2cm diameter. The plot is from the point where light
enters the skull bone (refer to figure 5.15).
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5.3.4 Simulating Fluence Buildup
The effect of fluence buildup is seen in Monte Carlo simulations near the photon source.
This effect largely depends on the albedo of the optical medium, where larger albedos
enhances this buildup effect compared to smaller values and is significant within 1mm
from the source in brain tissues. . While the Empirical can closely match the Monte
Carlo over diffusion region, the existing derived weights were inadequate to simulate
the fluence build up; therefore, a new set of weights were derived. Plots for the best
possible match in white matter, gray matter, skull bone, and astrocytoma are shown in
figures 5.19-5.22, respectively, and their corresponding weights are listed in table 5.3.
While the Empirical model may not exactly match Monte Carlo simulated data for both
the diffuse and near-source regions at the same time, it can modified to match the MC
based on the region of interest. One must note that the problem of fluence build occurs
within the first millimeter or two, thus a smaller voxel size will be required.
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Table 5.3 Weights derived to obtain fluence buildup
Tissue
Phantom
White Matter

Voxel Size
(mm)
0.1

Gray Matter
0.1
Skull Bone
0.1
Tumor
(Astrocytoma) 0.1

Wt1

Wt2

R-square

0.637486
0.711962
0.735052

0.090629
0.07201
0.066237

0.995372
0.999807
0.994337

0.89585

0.026037

0.955473

5.4

Discussion

In this specific aim, a reasonable accuracy (R-square of 0.999) was achieved between
the Empirical and the Monte Carlo for homogeneous and heterogeneous brain
phantoms and validated using the optical dosimetry probe. Overall, the empirical model
provides an alternate voxel based approach of estimating photon fluence in 3D
heterogeneous tissues besides the diffusion approximation and Monte Carlo methods.
Even though it was less accurate compared to Monte Carlo simulated data, (up to 36%%
error between probe and empirical), the reduction in computation times (8 hours per
MC simulation versus 4-12 seconds of Empirical simulation), provides a means for
clinical and preclinical applications, in particular for large data sets and iterative-based
optimization routines. Similar to the GPU MC code, it is easily integrated with existing
imaging modalities such as CT and MR due to its voxelated structure. In order to
simulate fine structural boundaries of brain tissues, we need a fine resolution of around
1mm, for which the CT dataset becomes very large. For such large datasets, where the
Monte Carlo cannot be run iteratively (>24 hours execution time), the empirical
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algorithm can replace the Monte Carlo for preliminary analysis. More study is required
to investigate the % match due to difference in the optimization routine and the
dependence of weights on the scattering properties of the medium. Further research is
also needed to understand the mismatch at object boundaries, particularly at larger
depths.
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6

SPECIFIC AIM4: IMAGE-GUIDED OPTICAL TRANSMISSION STUDIES IN HUMAN SKULL
BONES

6.1

Introduction

The skull forms an optical attenuator (absorber and scatterer) in the transmission of
near-Infra-red light to the brain. The success of any NIR based imaging or therapeutic
technique involving the brain depends on an accurate and precise determination of the
optical transmission properties of the skull. The skull bone consists of osteocytes and
calcium deposits in various densities and complex geometries based on different
anatomical locations in the skull. Previous studies have looked at the optical
transmission properties of different tissues [93-99] using collimated laser beams with
powers ranging from 10mW/cm2 to 25mW/cm2 [93, 94]. These studies included NIR
transmission through human cadaver skulls [94]. In our study, we used an NIR laser
source (17.64mW/cm2) with a complex super-Gaussian broad beam profile and
investigated if a relationship between voxel-based HU and optical attenuation exists.
Simulated Monte Carlo data was compared to measured beam intensity and distribution
implementing the TiO2-based optical dosimetry probe. This data was used to investigate
the relationship between the HU from CT images and the optical attenuation by
measuring the transmitted NIR light through human cadaver skulls Critical to these
measurements is the ability to quantify low power fluence transmitted through the skull

99
afforded with the TiO2 optical dosimetry probe compared to the calorimeter used in
previous bone transmission studies [91, 92].

To date, studies [80, 100-102] have measured the optical properties of the brain tissues,
have mapped the heterogeneity and inter-sample variations. The comparison of the
optical properties of skull bone found in these studies [80, 100-102] is shown in table 6.1.
It shows a wide variation in the optical properties reported for the human skull bone. A
comprehensive work by Bashkatov et al. [100] mapped these variations in optical
properties of the skull bone at different wavelengths. Our aim is to further understand
this complexity caused by variations in the bone density and bone thickness to map out
an accurate fluence map of the Monte Carlo in the brain. The use of Computed
Tomography images provides a 3D map of the heterogeneous bone structure and allows
us to accurately generate the boundary conditions and density maps using the Monte
Carlo.

Table 6.1 Optical properties of skull bone measured at 800nm wavelength in different
studies [80, 100-102]. The anisotropy factor (g) is 0.9.
Study By:

Absorption
Coefficient
-1
a) (cm )
Firbank et al.
0.24
Bashkatov et al. 0.11
Pifferi et al.
0.07
Ugryumova et al. 0.25

Scattering
Coefficient
-1
s) (cm )
18.4
19.48
12.5
21
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6.2

Materials and Methods

6.2.1 Optical Bone Dosimetry Setup
10 Different skull bone samples [courtesy: Lisa Hilliard (Medical Laboratory Science
Program) and Dr. James Walker (Dept. of Basic Medical Sciences)] were used for the
optical transmission study. The light source consisted of the optical fiberguide (see
chapter 2) connected to a laser source. The NIR output of the fiberguide was measured
using a calorimeter to be 19.94mW or (17.64 mW/cm2) at 800nm wavelength. For
transmission studies, the optical fiberguide was placed against the outer surface of the
skull bone, such that its aperture was flat against the bone surface, thus providing a
normal exposure. The fluence transmitted through the bone was measured using the
TiO2 dosimetry probe by placing it against the inner surface of the skull bone, opposite
the fiberguide on the other side of the skull, which was ensured by locating the point of
maximum fluence. The energy fluence for 5 points or locations per skull was acquired,
and at each location the measurement was repeated three times. A total of 10 cadaver
skull bones were measured, which gave a total of 50 measurement data points. The
setup for these experiments is shown in figures 6.1 and 6.2.
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Figure 6.2 Skull bone sample (top portion) used in the experiment. The dosimetry probe
is also seen.

Figure 6.3 Optical dosimetry setup for lateral beam profile measurement in skull sample.
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measurement for optical transmission lies on the inner skull boundary on the line while
lateral profile is measured at 0.5 cm from the inner skull surface.

In order to identify the source voxel for illumination, another line was drawn tangential
to the skull surface, passing through the intersection point of the bead and the outer
skull surface as shown in figure 6.5 (B). The cross product of the illumination vector and
the source tangential vector is the other vector which also lies tangential to the skull
surface along the z axis [0 0 1]. The source voxels are then identified as those lying on
the 3D circle defined by the two tangential vectors. The parametric equation used of a
3D circular disk [103] can be then used to represent the fiberguide source surface as
described by the two tangential vectors. Thus one can accurately represent any broad
source in the Monte Carlo at any arbitrary angle as used in the experimental setup.
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not used (incomplete CT scan). The optical transmission measurements show a wide
variation in the optical power transmitted, due to variation in skull thickness and
(heterogeneity in) bone densities. In order to map the Monte Carlo fluence to the %
transmission measurements of the probe, we used CT images to determine the optical
path-length through the bone (i.e. skull thickness in the direction of illumination). The
skull thicknesses measured using CT images showed different skull thicknesses both
within and across the skull samples. The measured skull thicknesses from the CT images
are shown in figure 6.9. We also measured the lateral beam profiles in the skull
phantoms in air and water as shown in figure 6.10. The measured probe voltage is seen
to be higher in water compared to air. This is mainly due to the difference in the skullmedium interface boundary conditions, such as the differences in the refractive indices
of skull bone and water versus skull bone and air.
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In order to demonstrate the feasibility of using CT image-guided skull boundaries for
Monte Carlo simulation, we used the CT images to map the heterogeneity in distribution
of bone voxels along with the geometry of boundaries. Figure 6.14 shows the
comparison between the lateral fluence profiles (transmitted through the skull
immersed in water) measured using the probe versus the Monte Carlo. The boundary
conditions derived from the CT images is shown in figure 6.15. The fluence profiles were
normalized to the maximum value measured at a depth of 5mm from the inner surface
of the skull bone. The results show a close match between the beam spread simulated
by the Monte Carlo and measured by the probe. This demonstrates the accuracy with
which the scattering properties of the bone were modelled, along with the CT image
enhanced boundary conditions. The CT images of the skull sample also show the
changing Hounsfield CT numbers across the bone which is the result of varying density
of the bone structure. Thus compared to previous studies, we have used the CT images
to account for the different optical path lengths along with boundary conditions. We
have however, not accounted for the varying densities of the bone, which results in
differences between the probe and the Monte Carlo fluences.

6.4

Discussion

The optical transmission study demonstrates the difficulties encountered in optical bone
transmission studies. The Monte Carlo can accurately simulate photon attenuation in
the skull only when all the optical properties and boundary conditions are simulated
correctly. While the skull bone has been measured and modelled as a relatively
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homogeneous medium in optical simulation studies, the use of CT images shows that it
is far from homogeneous with wide variations in bone densities at different anatomical
regions and across subjects. This presents a complicated scenario to model the optical
propagation of photons through the skull.

We demonstrated the accuracy of boundary conditions determined using CT images by
comparing the lateral profiles between the Monte Carlo and the dosimetry probe. The
close match between the profiles shows the accuracy of our simulations. Our study thus
also reduced the error in measuring skull thicknesses using calipers, which so often goes
unnoticed in complex tissue structure. For example: an error in correctly measuring the
skull thickness by a millimeter can result in errors of up to 40% in magnitude (seen from
our MC data in figures 6.11, 6.12), depending on the boundary and illumination
conditions. Thus any imaging or therapeutic technique needs to reduce the errors due
to mismatch in the boundary conditions by using an anatomical imaging technique (such
as CT) which can map different tissue boundaries.

To improve the match between the Monte Carlo and the measured fluence in skull
models, we hypothesize that using bone density measurement technique such as
quantitative CT can significantly improve the localization of high scattering bone voxels
in the skull bone. The mapping of Hounsfield values of CT number can be directly linked
to the bone density values by imaging bone density phantoms in the CT scanner. This
would provide volumetric images of bone densities which can be converted (scaled) to
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the corresponding scattering absorption coefficients. The optical coefficient scaling will
also need to be calibrated by measuring the optical properties of bone samples of
known density.
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7

7.1

DISCUSSION

Design and Calibration of Optical Dosimetry Probe

We designed and calibrated an optical dosimetry probe with a linear and isotropic
response to input photon fluence. While several designs of the dosimetry probe exist in
the medical optics market, the application of a specific dosimetry probe for an
application mainly depends on probe sensitivity to the wavelengths of interest. The
isotropicity of the dosimetry probes used in past studies is shown in table 7.1. The
choice of the titanium dioxide for the probe was made to achieve maximum sensitivity
by maximizing scattering near 800nm wavelength through the use of Titanium Dioxide
(by Du Pont [71]). We were able to prove that the sensitivity as well as the angular
response of the TiO2 probe is superior to that of the conventional Nylon based probes.
The next innovative aspect of our study was the determination of absolute photon
fluence from the probe response. By using the linear relationship between the probe
and calorimeter responses, along with the experimental derivation of a calibration
factor for relating probe response in air to that in water, we were able to derive the
mathematical relationship to absolutely quantify photon fluence in tissues for in-vitro or
in-vivo studies in the future. This provides a simple technique to quantify probe
response experimentally for validation purposes.
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Table 7.1 Optical dosimetry probe composition (diameter<2mm) and % isotropicity
variation [68, 69].
Study By:

Probe tip material

Marijnissen et al
Marijnissen et al
Van Staveren et al
Our study
Our study

ArniteTM
NylonTM
Helioseal (dental sealant)
TiO2 (best probe)
NylonTM (best probe)

7.2

Isotropicity
Variation %
11%
11%
20%
13%
17%

Dosimetric Validation of a Monte Carlo based Optical Planning tool

The Monte Carlo based tool for photon dose estimation was successfully optimized and
validated, using optical dosimetry probe measurements, to study light dose delivery to
brain tissue phantoms. Past studies have compared the dosimetry probe measurements
with simpler models (non voxelated) of the Monte Carlo along illumination axis in
homogeneous phantoms and tissues for simpler (flat or isotropic) beam profiles (flat
beams) [104-106]. The long computation times (several hours to days) associated with
the Monte Carlo prevented any rigorous approach for validation across diverse tissues
and illuminations. To the best of our knowledge, this is the first study which has sought
to rigorously validate a 3D voxelated GPU based Monte Carlo using dosimetry probe
measurements both along and perpendicular to the illumination axis, in homogeneous
and heterogeneous tissue phantoms with independently derived optical properties, and
using a complex super-Gaussian beam profile. We also validated the Monte Carlo in a
diffuse beam generated by an integrating sphere, thus proving the flexibility of the
Monte Carlo in accurately generating different beam profiles.
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A past validation study [106] had compared the angular radiance with different viewing
angles using a flat cleaved probe to the Monte Carlo in tissue phantoms. The measured
versus Monte Carlo fluence showed a % error variation from 0 to 25% (seen from the
figure 6 plot in the publication) along the beam axis, mainly due to mismatch in optical
properties. In another study [105], Monte Carlo validation using dosimetry in a dissected
Pig Bronchus tissue showed higher % mismatch of around 50% at a 4cm depth, with
measurement error amounting to 15% variation. The other significant part of the error
was accounted for by the variation in estimation of the tissue optical properties and
tissue boundaries. This demonstrates the importance of independent validation of
optical properties of the medium along with an accurate simulation of boundary
conditions in the Monte Carlo. In this study, the average % error was well within 25% for
most of our measurements. The acceleration provided by the GPU platform improves
the applicability of the Monte Carlo by reducing the development time associated with
iteratively optimizing the accuracy of the boundary and illumination conditions, which
was difficult to achieve in the CPU based model.

7.3

An Empirical algorithm for preliminary optical dose planning

The brain is a highly heterogeneous structure and has complex distribution of tissues
with varying optical properties. In order to target a metastatic site in the brain we need
to be able to optimize the light delivery to that region in the brain, which requires us to
analyze multiple light source positions, orientations as well as source illumination
profiles; all of which affect the path that photons travel through the brain. Since this
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requires iterative techniques, multiple simulations of photon propagation with different
illumination conditions require a tool which is faster than the Monte Carlo (run time a
few hours). Hence an alternative Empirical model with a run time of a few seconds was
designed as a preliminary investigation tool with a reasonable level of accuracy
compared to the Monte Carlo in heterogeneous tissues.

The Empirical model is based on the photon convolution algorithm and uses weights to
simulate photon scatter from one voxel to another. Its 3D voxel based design helps us to
integrate it with the Monte Carlo along with 3D imaging modalities such as CT and MR.
The empirical algorithm was iteratively optimized with the Monte Carlo and tested in
optical phantoms resembling a child’s brain with and without a tumor. We found a
reasonable degree of match between the Monte Carlo and the Empirical in both
homogeneous and heterogeneous tissues. The lateral profiles in homogeneous
phantoms were also compared and were found to match between the two models.

The errors in the Empirical model include boundary conditions which the Empirical in
not able to simulate as well as the Monte Carlo. Further research is necessary to
investigate and optimize the Empirical algorithm to make it more accurate in complex
heterogeneous tissues. Due to its reasonable degree of accuracy, the Empirical
algorithm can be used as a preliminary investigation tool to narrow down the optimal
illumination conditions while the Monte Carlo can be the Gold standard for the final
dose calculation. A comparison of various models used in past studies is shown in table
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7.2. The Empirical approach performs favorably with its moderate level of accuracy and
fast execution times with respect to Monte Carlo.

Table 7.2 Methods for photon propagation [61, 107-111]. Estimated simulation times
for a head study.
Method:

Execution
time

Advantages

Disadvantages

CPU based Monte
Carlo [110]
GPU based Monte
Carlo [61]
Radiative
Transport
Equation (RTE)
[108]
Diffusion
Approximation
(DE) [107, 111]

>24 hours
(1-3 days)
4-8 hours

Accurate

Long execution
times
Moderate execution
time
Complex to solve

Hybrid model (MC
+ DE) [109]
Empirical Model
[64]

7.4

Accurate

Few
minutes

Accurate

Few
seconds

Accurate only at large
distances from source, at
g<0.6 and at higher
albedos (μs/ μs+ μa)

Errors at short
distances from
source, at g>0.6 and
at lower albedos
(μs/ μs+ μa)

1-3 hours

Moderate accuracy (1-2
std dev)
Moderate accuracy

Moderate accuracy
(1-2 std dev)
Non-analytical
technique

4-12
seconds

Image guided transmission studies in skull bone phantoms

The NIR transmission study demonstrates the complexities of modelling the optical
properties of the skull bone. Past studies measuring the NIR transmission through skulls
had measured the transmission through cadaver skulls with intact soft tissues [93, 94].
This resulted in larger uncertainties in the optical properties (with the inclusion of soft
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tissue). No image based technique was used in these studies to determine the optical
pathlength through the samples. In this study we measured NIR transmission through
pure skull bone samples without any soft tissue, and demonstrated the use of image
guided technique to determine the bone thickness. We also successfully demonstrated
the close match between the lateral beam profiles measured in water, which shows the
importance of using image guided techniques to map heterogeneity of the skull. While
the transmission errors between the Monte Carlo and the probe measurements are
significant for some measurement points, this study tries to point at the scope for future
investigation into the heterogeneous density distribution of scatterers in the skull bone.
There is a need to model the varying optical scattering of the bone based on bone
density. Methods such as bone densitometry and quantitative CT can be used to
calculate skull bone densities and can potentially improve the accuracy of the Monte
Carlo.
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8

FUTURE WORK

While this study has looked specifically at building optical dosimetry and photon dose
simulation tools with an intention of future application in light induced drug activation
in the brain, we are still some distance away from accurately modelling the drug release
maps in the brain. This is mainly due to a lack of understanding of the mechanism for
drug activation. While in vitro experiments as well as in vivo studies in mice have shown
promising results, the energy threshold for drug release is still uncertain. The drugnanocomplex molecule consists of a therapeutic drug molecule (e.g. lapatinib) which is
complexed with a gold plated silica nanoshell [8]. These nano-complexes are incubated
in macrophages and monocytes and injected into the blood stream, cross the blood
brain barrier, and accumulate in the metastatic lesions in the brain [8, 9]. Thus when
irradiated with an NIR source with sufficiently high power, the high absorption crosssection of gold nanocomplexes results in heating of the nanoparticles [86, 87] which can
lead to breakage of bonds binding the drug (or any fluorescent molecule) to the nanocomplex and subsequent release and activation of the drug [8, 9]. The resulting rise in
temperature has been shown to be around 37.40C as shown in previous studies [86] for
a power of 4W/cm2. The heating property of the gold nanoshell nano-complex can be
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tuned by changing the size of the silica nano-shell compared to that of the outer gold
plated layer [88], which allows us to optimize the drug molecule with respect to the
wavelength of light delivery. While this shows significant promise in the mechanism of
temperature rise leading to drug release, more research needs to be done to
understand the temperature related dependence of the drug release.

In order to control the rise in temperature in the region surrounding the nanocomplex
molecules, the instantaneous energy provided to a tissue region can be controlled by
adjusting the pulse width of the laser beam. The use of pulsed laser beams has been
shown to improve the instantaneous temperature rise and release in of drug molecules
tethered to nanoparticles, compared to continuous wave lasers [112]. This will allow
more instantaneous power to be coupled to the nano-molecules while reducing the
chances of laser induced adverse tissue heating or denaturing of the drug. The
maximum energy that can be safely coupled to tissues is limited by the maximum
permissible exposure (MPE). MPE values are based on the pulse duration and the tissue
type [113, 114]. For example, if we use a laser beam of 1 ns pulse duration, the MPE to
the skin is 3.17x107 W cm-2 [113, 114]. Based on our prior Monte Carlo simulations using
a flat 2cm diameter beam, the amount of power coupled to the soft tissue for 1.1cm
and 0.2cm thick adult and neonatal skull is 4.3x105 W cm-2 and 1.5x107 W cm-2,
respectively. Thus, a therapeutic drug molecule needs to be designed such that it can be
activated at a threshold less than the maximum permissible power coupled to tissues at
a specific depth. For example, a drug molecule with an energy threshold of 1 Wcm-2 can

127
be released up to a depth of 3.8cm in the white matter of an adult brain (skull thickness
1.1cm, gray matter thickness 2cm), and up to 4.6cm in a neonatal brain (skull thickness
0.2cm, gray matter thickness 0.2cm) for a flat beam of 2cm diameter, 1ns temporal
spread and an input fluence of 3.17x107 W cm-2. This shows that the structure of the
brain and path lengths through the tissue can significantly impact the fluence coupled
and the effectiveness of therapy. However, these results demonstrate the feasibility of
NIR stimulated drug release, in particular for children where 4.6cm is more than half the
diameter of the brain cavity.

Even though reducing the laser pulse width can enhance drug release without
denaturing the drug or heating the tissue, it can also significantly impact the
instantaneous or peak energy fluence within the brain. Multiple scattering in brain
tissues causes the photons to travel with different optical path-lengths, thus
simultaneously increasing the pulse width and decreasing the peak power at greater
depths. Past studies have measured the temporal dispersion of laser beams in scattering
tissues by using time of flight method with a fast optical detector [115, 116], or by using
radio frequency (RF) modulated light source by detecting the phase of transmitted light
[117, 118]. A theoretical basis of calculation of the temporal point spread function is
also provided by Arridge [115] using the temporal point spread function (TPSF), while
the TPSF is the “response function (Green’s Function) of the medium to a delta impulse”
[115]. The Monte Carlo used in this study has the ability to simulate photon pulses with
user-defined pulse duration. In our MC simulation studies, we calculated the temporal
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dispersion of a 1ns laser beam by measuring the full width at tenth maximum of the
laser pulse as it propagated along a circular head phantom (boundary conditions shown
in figure 5.11). The plot of temporal pulse width to the depth in the tissue is displayed in
figure 8.1. The pulse width is seen to increase by 4-5 times at depths of 3-5cm. This
implies a reduction in the fluence per unit time by approximately this same amount. The
pulse width was measured by calculating the full width at tenth maximum, a quantity
which determines the pulse duration up to 10% of maximum fluence. Therefore, some
care must be taken when considering the pulse width in the design of the treatment
plan. To date, the Monte Carlo can be used to predict this spread to optimize drug
release. Further temporal convolution methods may need to be added to the empirical
model.

129

Figure 8.1 MC simulation of temporal pulse width versus depth in a heterogeneous head
phantom (see figure 5.11) for an input pulse 1ns wide. The pulse width was measured
by calculating the Full Width at Tenth Maximum (FWTM) to analyze the temporal beam
spread.

There is a need to quantify the errors due to variability of brain tissue properties,
particularly the skull bone between different patients. The skull bone thickness and
density varies across different anatomical regions of the brain [89]. The optical
properties of the skull bone are also seen to vary across samples [89], which can result
in differences between the estimation and delivery of photon fluence to metastatic
tissue in the brain. Hence the need for using a medical imaging system such as
Computed Tomography (CT) is necessary to segment tissues in the brain, especially the
bone-brain interface. In our study the average % error in determining bone thickness

130
measured using versus a scale was 30%. Thus modelling the skull heterogeneity using CT
images has the potential to reduce simulation errors of up to 73% in the fluence coupled
to soft tissue in adult brains and up to 20% in neonatal brains with respective skull
thicknesses of 1.1cm and 0.2 cm.

While the bone-brain interface is clearly visible using CT images, better soft tissue
contrast is necessary to segment different soft tissues such as white matter, gray matter,
cerebrospinal fluid and metastatic lesions (if any) in the brain. This is best done using
Magnetic Resonance Images (e.g. T2-weighted), which are also used as the standard
imaging protocol to segment metastatic lesions in the brain [90]. The MR images
however cannot be used to image the bone-brain interface, as bone images of the brain
are generally poor. Hence there is a need to super-impose and co-register CT and MR
images of patients about to undergo optical therapy. This would provide a significant
improvement in brain tissue segmentation over CT-only or MR-only based imaging and
segmentation methods. The co-registration software (e.g. Gamma Plan [91, 92]) used
needs to be highly accurate to ensure minimal errors in boundary conditions which need
to be accurately depicted by the Monte Carlo. Phantom studies to determine image
registration accuracy [92] can be done to quantify any errors related to inaccurate tissue
boundaries.

8

LIST OF REFERENCES

131

LIST OF REFERENCES

1. Niwinska A, Murawska M, Pogoda K (2010), Breast cancer brain metastases:
differences in survival depending on biological subtype, RPA RTOG prognostic
class and systemic treatment after whole-brain radiotherapy (WBRT). Ann Oncol
21: 942–948.
2. Lin NU, Claus E, Sohl J, Razzak AR, Arnaout A, Winer EP (2008), Sites of distant
recurrence and clinical outcomes in patients with metastatic triple-negative
breast cancer: high incidence of central nervous system metastases. Cancer
113(10):2638–2645.
3. Amer, M. H., Al-Sarraf, M., Baker, L. H. and Vaitkevicius, V. K. (1978), Malignant
melanoma and central nervous system metastases. Incidence, diagnosis,
treatment and survival. Cancer, 42: 660–668.
4. Chang E, Wefel JS, Hess KR, et al. (2009), Neurocognition in patients with brain
metastases treated with radiosurgery or radiosurgery plus whole-brain
irradiation: a randomized controlled trial. Lancet Oncol; 10: 1037–44.
5. Sneed PK, Lamborn KR, Forstner JM, McDermott MW, Chang S, Park E, Gutin PH,
Phillips TL, Wara WM, Larson DA (1999), “Radiosurgery for brain metastases: is
whole brain radiotherapy necessary?” Int J Radiat Oncol Biol Phys 43(3):549–558.

132
6. Patchell RA, Regine WF (2003), “The rationale for adjuvant whole brain radiation
therapy with radiosurgery in the treatment of single brain metastases.” Tech
Canc Res Treat 2(2):111–115.
7. Lo SS, Chang EL, Suh JH (2005), Stereotactic radiosurgery with and without
whole-brain radiotherapy for newly diagnosed brain metastases. Expert Rev
Neurother 5(4):487–495.
8. Choi MR, Stanton-Maxey KJ, Stanley JK, Levin CS, Bardhan R, Akin D, Badve S,
Sturgis J, Robinson JP, Bashir R, Halas NJ, Clare SE. “A cellular Trojan Horse for
delivery of therapeutic nanoparticles into tumors.” Nano Lett 7(12) (2007):
37593765.
9. Mi-Ran Choi, Rizia Bardhan, Katie J. Stanton-Maxey, Sunil Badve, Harikrishna
Nakshatri, Keith Stantz, Ning Cao, Naomi J. Halas, Susan E. Clare (2012), Delivery
of nanoparticles to brain metastases of breast cancer using a cellular Trojan
horse. Cancer Nano 3: 47-54.
10. Kelly, P. M., et al. "Macrophages in human breast disease: a quantitative
immunohistochemical study." British journal of cancer 57.2 (1988): 174.
11. McBride, W. H. "Phenotype and functions of intratumoral macrophages.”
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 865.1 (1986): 27-41.
12. STEELE, R.J.C., BROWN, M. & EREMIN, 0. (1985). Characterization of
macrophages infiltrating human mammary carcinomas. Br. J. Cancer, 51, 135.

133
13. Lwin, K.Y. Zuccarini, O., SLOANE, J.P. & BEVERLEY, P.C.L. (1985). An
immunohistological study of leucocyte localization in benign and malignant
breast tissue. Int. J. Cancer, 36, 433.
14. Kelly, P. M., et al. "Monoclonal antibody EBM/11: high cellular specificity for
human macrophages." Journal of clinical pathology 41.5 (1988): 510-515.
15. Bliss, E., et al. "Quantitation of macrophages in human-breast cancer using
monoclonal-antibody (ebm11) to human macrophages." Journal Of Pathology.
Vol. 143. No. 1. Baffins Lane Chichester, W Sussex, England Po19 1ud: John Wiley
& Sons Ltd, 1984.
16. Kruger, R. A., et al. "Thermoacoustic optical molecular imaging of small
animals,[Mol." (2003): 113-123.
17. Kruger, Robert A., Daniel R. Reinecke, and Gabe A. Kruger. "Thermoacoustic
computed tomography–technical considerations." Medical physics 26.9 (1999):
1832-1837.
18. Kruger, Robert A., Pingyu Liu, and C. Robert Appledorn. "Photoacoustic
ultrasound (PAUS)—reconstruction tomography." Medical physics 22.10 (1995):
1605-1609.
19. Kruger, Robert A., and Pingyu Liu. "Photoacoustic ultrasound: Pulse production
and detection in 0.5% Liposyn." Medical physics 21.7 (1994): 1179-1184.
20. Wang, Lihong V., ed. Photoacoustic imaging and spectroscopy. CRC press, 2009.

134
21. Jacques, Steven L. "Coupling 3D Monte Carlo light transport in optically
heterogeneous tissues to photoacoustic signal generation." Photoacoustics2.4
(2014): 137-142.
22. Cox, Benjamin T., et al. "Two-dimensional quantitative photoacoustic image
reconstruction of absorption distributions in scattering media by use of a simple
iterative method." Applied Optics 45.8 (2006): 1866-1875.
23. Patrikeev, Igor, et al. "Monte Carlo modeling of optoacoustic signals from human
internal jugular veins." Applied optics 46.21 (2007): 4820-4827.
24. Cheong, Yaw Jye, and Keith M. Stantz. "Photon propagation correction in 3D
photoacoustic image reconstruction using Monte Carlo simulation." BiOS.
International Society for Optics and Photonics, 2010.
25. Yalavarthy, Phaneendra K., et al. "Experimental investigation of perturbation
Monte-Carlo based derivative estimation for imaging low-scattering
tissue."Optics express 13.3 (2005): 985-997.
26. Kumar, Y. Phaneendra, and Ram M. Vasu. "Reconstruction of optical properties
of low-scattering tissue using derivative estimated through perturbation MonteCarlo method." Journal of biomedical optics 9.5 (2004): 1002-1012.
27. Jobsis, Frans F. "Noninvasive, infrared monitoring of cerebral and myocardial
oxygen sufficiency and circulatory parameters." Science 198.4323 (1977): 12641267.
28. Elwell, C. E., et al. "Quantification of adult cerebral hemodynamics by nearinfrared spectroscopy." Journal of Applied Physiology 77.6 (1994): 2753-2760.

135
29. Delpy, David T., et al. "Estimation of optical pathlength through tissue from
direct time of flight measurement." Physics in medicine and biology 33.12 (1988):
1433.
30. Grinvald, Amiram, et al. "Functional architecture of cortex revealed by optical
imaging of intrinsic signals." (1986): 361-364.
31. Haglund, Michael M., George A. Ojemann, and Daryl W. Hochman. "Optical
imaging of epileptiform and functional activity in human cerebral
cortex."Nature 358.6388 (1992): 668-671.
32. Chance, B., et al. "Comparison of time-resolved and-unresolved measurements
of deoxyhemoglobin in brain." Proceedings of the National Academy of
Sciences 85.14 (1988): 4971-4975.
33. Hoshi, Y. O. K. O., and M. A. M. O. R. U. Tamura. "Dynamic multichannel nearinfrared optical imaging of human brain activity." Journal of Applied
Physiology 75.4 (1993): 1842-1846.
34. Kato, Toshinori, et al. "Human visual cortical function during photic stimulation
monitoring by means of near-infrared spectroscopy." Journal of Cerebral Blood
Flow & Metabolism 13.3 (1993): 516-520.
35. Villringer, Arno, et al. "Near infrared spectroscopy (NIRS): a new tool to study
hemodynamic changes during activation of brain function in human
adults." Neuroscience letters 154.1 (1993): 101-104.

136
36. Gratton, Gabriele, et al. "Shades of gray matter: Noninvasive optical images of
human brain reponses during visual stimulation." Psychophysiology 32.5 (1995):
505-509.
37. Villringer, Arno, and Britton Chance. "Non-invasive optical spectroscopy and
imaging of human brain function." Trends in neurosciences 20.10 (1997): 435442.
38. Powers, William J. "Hemodynamics and metabolism in ischemic cerebrovascular
disease." Neurologic clinics 10.1 (1992): 31-48.
39. Tachibana, Hisao, et al. "Xenon Contrast CT–CBF Scanning of the Brain
Differentiates Normal Age-Related Changes from Multi-infarct Dementia and
Senile Dementia of Alzheimer Type." Journal of gerontology 39.4 (1984): 415-423.
40. Edwards, A. D., et al. "Measurement of hemoglobin flow and blood flow by nearinfrared spectroscopy." Journal of Applied Physiology 75.4 (1993): 1884-1889.
41. Richter, C-P., et al. "Neural stimulation with optical radiation." Laser & photonics
reviews 5.1 (2011): 68-80.
42. Chernov, Mykyta, and Anna Wang Roe. "Infrared neural stimulation: a new
stimulation tool for central nervous system applications." Neurophotonics 1.1
(2014): 011011-011011.
43. Thompson, Alexander C., et al. "Modeling of light absorption in tissue during
infrared neural stimulation." Journal of biomedical optics 17.7 (2012): 07500210750026.

137
44. Polikov, Vadim S., Patrick A. Tresco, and William M. Reichert. "Response of brain
tissue to chronically implanted neural electrodes." Journal of neuroscience
methods 148.1 (2005): 1-18.
45. Boyden, Edward. "A history of optogenetics: the development of tools for
controlling brain circuits with light." (2011).
46. Yizhar, Ofer, et al. "Optogenetics in neural systems." Neuron 71.1 (2011): 9-34.
47. Wells, Jonathon, et al. "Optical stimulation of neural tissue in vivo." Optics
letters 30.5 (2005): 504-506.
48. Wells, Jonathon, et al. "Biophysical mechanisms of transient optical stimulation
of peripheral nerve." Biophysical journal 93.7 (2007): 2567-2580.
49. Shapiro, Mikhail G., et al. "Infrared light excites cells by changing their electrical
capacitance." Nature communications 3 (2012): 736.
50. Chandrasekhar S. Radiative transfer, ed. Chandrasekhar, S. (1960): 20.
51. W. Cheong, S. A. Prahl, and A. Welch, “A review of the optical properties of
biological tissues,” in IEEE journal of quantum electronics, vol. 26, (1990): 2166–
2185.
52. W. M. Star. Comparing the P3-approximation with diffusion theory and with
Monte Carlo calculations of light propagation in a slab geometry. in SPIE
Proceedings on Dosimetry of Laser Radiation in Medicine and Biology, vol. IS5,
(1989): 146- 154.

138
53. G. Yoon, S. A. Prahl and A. J. Welch. ”Accuracies of the Diffusion Approximation
and its Similarity Relations for Laser Irradiated Biological Media.” in Applied
Optics, vol. 28, (1989): 2250-2255.
54. Henyey, Louis G., and Jesse Leonard Greenstein. "Diffuse radiation in the
galaxy." The Astrophysical Journal 93 (1941): 70-83.
55. J. H. Joseph, W. J. Wiscombe, and J. A. Weinman, "The DeltaEddington
Approximation for Radiative Flux Transfer," J. Atm. Sci. 33, 2452-2459 (1976).
56. M. J. C. Gemert, A. J. Welch, W. M. Star, M. Motamedi, and W. F. Cheong. Tissue
optics for a slab geometry in the diffusion approximation, in Lasers Med. Sci., vol.
2, (1987): 295-302.
57. L. Wang, S. L. Jacques, and L. Zheng, “Monte Carlo modeling of light transport in
multilayered tissues.” Computer Methods and Programs in Biomedicine, vol. 47,
(1995): 131-146.
58. D. A. Boas, J. P. Culver, J. J. Stott, and A. K. Dunn. “Three dimensional Monte
Carlo code for photon migration through complex heterogeneous media
including the adult human head.” in Opt. Express, vol. 10, (2002): 159170.
59. J. Cheong, Monte Carlo simulation for light propagation through tissues,
Master’s Thesis, Department of Biomedical Engineering, Purdue University, 2009.
60. A. Prabhu Verleker, Monte Carlo simulation to study light propagation through
biological tissues, Master’s Thesis, Department of Biomedical Engineering,
Purdue University, 2011.

139
61. Q. Fang and D. A. Boas, "Monte Carlo simulation of photon migration in 3D
turbid media accelerated by graphics processing units," in Opt. Express, vol. 17,
pp. 20178-20190, 2009.
62. Verleker, A. P., Fang, Q., Choi, M. R., Clare, S., Stantz, K. M. "An optical
therapeutic protocol to treat brain metastasis by mapping NIR activated drug
release: A pilot study." 2014 IEEE Nuclear Science Symposium and Medical
Imaging Conference (NSS/MIC). IEEE, 2014.
63. Verleker, A. P., Fang, Q., Choi, M. R., Clare, S., Stantz, K. M. “Dosimetric
Validation of a Monte Carlo based Optical Planning tool.” Draft to be submitted
to Applied Optics, 2016.
64. Verleker, A. P., Fang, Q., Choi, M. R., Clare, S., Stantz, K. M. “An empirical
approach to estimate near-infra-red photon propagation and optically induced
drug release in brain tissues.” in SPIE BiOS International Society for Optics and
Photonics (2015, March): 93080T-93080T.
65. I. Lux and L. Koblinger, Monte Carlo Particle Transport Methods: Neutron and
Photon Calculation, CRC Press, vol. 102, 1991.
66. E. D. Cashwell and C. J. Everett, A Practical Manual on the Monte Carlo Method
for Random Walk Problems, New York: Pergamon Press, 1959.
67. M. H. Kalos and P. A. Whitlock, Monte Carlo Methods, John Wiley & Sons, Inc.,
1986.

140
68. Marijnissen, J. P. A., and W. M. Star. “Calibration of isotropic light dosimetry
probes based on scattering bulbs in clear media.” Physics in medicine and
biology 41.7 (1996): 1191.
69. Van Staveren, Marijnissen J P A, Aalders M C G and W. M. Star. ”Construction,
quality assurance and calibration of spherical isotropic fibre optic light diffusers.”
Lasers Med Sci, (1995). 10(2): p. 137147.
70. Shaffer M. ”Dynamic Contrast Enhanced Photoacoustic Computed Tomography
in MDA-MB-231 and BT-474 Xenograft Tumor Models,” PhD Thesis, Purdue
University (2012), 54-67.
71. DuPont Titanium Technologies, Titanium Dioxide for Coatings. Coatings selection
brochure P200067, (2002): Wilmington, DE.
72. Marijnissen, J. P. A., and W. M. Star. “Performance of isotropic light dosimetry
probes based on scattering bulbs in turbid media.” Physics in medicine and
biology 47.12 (2002): 2049.
73. Pogue, Brian W., and Michael S. Patterson. "Review of tissue simulating
phantoms for optical spectroscopy, imaging and dosimetry." Journal of
biomedical optics 11.4 (2006): 041102-041102.
74. Madsen, Steen J., Michael S. Patterson, and Brian C. Wilson. ”The use of India ink
as an optical absorber in tissue-simulating phantoms.” Physics in medicine and
biology 37.4 (1992): 985.
75. Driver, I., et al. ”The optical properties of aqueous suspensions of Intralipid, a fat
emulsion.” Physics in medicine and biology 34.12 (1989): 1927.

141
76. Van Staveren, Hugo J., et al. ”Light scattering in lntralipid-10% in the wavelength
range of 400 1100 nm.” Applied optics 30.31 (1991): 4507-4514.
77. Flock, Stephen T., et al. ”Optical properties of Intralipid: a phantom medium for
light propagation studies.” Lasers in Surgery and Medicine 12.5 (1992): 510519.
78. https://en.wikipedia.org/w/index.php?title=Beer%E2%80%93Lambert_law&oldi
d=718072472; last accessed May 11, 2016.
79. Van der Zee, Pieter, Matthias Essenpreis, and David T. Delpy. ”Optical properties
of brain tissue.” OE/LASE’93: Optics, Electro-Optics, and Laser Applications in
Science and Engineering. International Society for Optics and Photonics, (1993).
80. M. Firbank, M. Hiraoka, M. Essenpreis, D.T. Delpy. ”Measurement of the optical
properties of the skull in the wavelength range 650-950 nm,” Phys. Med. Biol., 38
(1993):503-510.
81. Irvine, William M., and James B. Pollack. ”Infrared optical properties of water
and ice spheres.” Icarus 8.1 (1968): 324-360.
82. Hielscher, Andreas H., Raymond E. Alcouffe, and Randall L. Barbour.
"Comparison of finite-difference transport and diffusion calculations for photon
migration in homogeneous and heterogeneous tissues." Physics in medicine and
biology 43.5 (1998): 1285.
83. https://en.wikipedia.org/wiki/Radiative_transfer_equation_and_diffusion_theor
y_for_photon_transport_in_biological_tissue; last accessed May 11, 2016.

142
84. Flock, S.T.; Patterson, M.S.; Wilson, B.C.; Wyman, D.R., "Monte Carlo modeling of
light propagation in highly scattering tissues. I. Model predictions and
comparison with diffusion theory," Biomedical Engineering, IEEE Transactions
on vol.36, no.12, (1989): 1162, 1168.
85. Wang, Lihong, Steven L. Jacques, and Liqiong Zheng. "CONV—convolution for
responses to a finite diameter photon beam incident on multi-layered
tissues." Computer methods and programs in biomedicine 54.3 (1997): 141-150.
86. Hirsch, L_R, et al. "Nanoshell-mediated near-infrared thermal therapy of tumors
under magnetic resonance guidance." Proceedings of the National Academy of
Sciences 100.23 (2003): 13549-13554.
87. O'Neal, D. Patrick, et al. "Photo-thermal tumor ablation in mice using near
infrared-absorbing nanoparticles." Cancer letters 209.2 (2004): 171-176.
88. Oldenburg, Steven J., et al. "Infrared extinction properties of gold
nanoshells." Applied Physics Letters 75.19 (1999): 2897-2899.
89. Bashkatov, Alexey N., et al. "Optical properties of human cranial bone in the
spectral range from 800 to 2000 nm." Saratov Fall Meeting 2005: Optical
Technologies in Biophysics and Medicine VII. International Society for Optics and
Photonics, 2006.
90. Law, Meng, et al. "High-Grade Gliomas and Solitary Metastases: Differentiation
by Using Perfusion and Proton Spectroscopic MR Imaging 1."Radiology 222.3
(2002): 715-721.

143
91. Marcu, S. M., et al. "GammaPlan®—Leksell Gamma Knife® radiosurgery
treatment planning verification method." Medical physics 27.9 (2000): 21462149.
92. Watanabe, Yoichi, and Eunyoung Han. "Image registration accuracy of
GammaPlan: a phantom study." (2008).
93. Jagdeo, Jared R., et al. "Transcranial red and near infrared light transmission in a
cadaveric model." PloS one 7.10 (2012): e47460.
94. Lychagov, Vladislav V., et al. "Experimental study of NIR transmittance of the
human skull." Biomedical Optics 2006. International Society for Optics and
Photonics, 2006.
95. Stolik, S., et al. "Measurement of the penetration depths of red and near infrared
light in human “ex vivo” tissues." Journal of Photochemistry and Photobiology B:
Biology 57.2 (2000): 90-93.
96. Tauber, Stefan, et al. "Lightdosimetric quantitative analysis of the human
petrous bone: Experimental study for laser irradiation of the cochlea." Lasers in
surgery and medicine 28.1 (2001): 18-26.
97. Wedel, H. V., et al. "Soft-laser/ginkgo therapy in chronic tinnitus." (1995): 105108.
98. Plucin, Jerzy, et al. "Theoretical foundations for noninvasive measurement of
variations in the width of the subarachnoid space." Journal of biomedical
optics 5.3 (2000): 291-299.

144
99. Young, A. E., et al. "Behaviour of near-infrared light in the adult human head:
implications for clinical near-infrared spectroscopy." British Journal of
Anaesthesia 84.1 (2000): 38-42.
100. Bashkatov, Alexey N., et al. "Optical properties of human cranial bone in the
spectral range from 800 to 2000 nm." Saratov Fall Meeting 2005: Optical
Technologies in Biophysics and Medicine VII. International Society for Optics and
Photonics, 2006.
101. Pifferi, Antonio, et al. "Optical biopsy of bone tissue: a step toward the
diagnosis of bone pathologies." Journal of biomedical optics 9.3 (2004): 474-480.
102. Ugryumova, Nadya, Stephen John Matcher, and Don P. Attenburrow.
"Measurement of bone mineral density via light scattering." Physics in medicine
and biology 49.3 (2004): 469.
103. http://demonstrations.wolfram.com/ParametricEquationOfACircleIn3D/; last
accessed May 29, 2016.
104. Star, Willem M. "Light dosimetry in vivo." Physics in medicine and biology42.5
(1997): 763.
105. Murrer, L. H. P., J. P. A. Marijnissen, and W. M. Star. "Ex vivo light dosimetry
and Monte Carlo simulations for endobronchial photodynamic therapy." Physics
in medicine and biology 40.11 (1995): 1807.
106. Barajas, Oscar, et al. "Monte Carlo modelling of angular radiance in tissue
phantoms and human prostate: PDT light dosimetry." Physics in medicine and
biology 42.9 (1997): 1675.

145
107. Fang, Qianqian, et al. "Combined optical imaging and mammography of the
healthy breast: optical contrast derived from breast structure and
compression." IEEE transactions on medical imaging 28.1 (2009): 30-42.
108. Joshi, Amit, et al. "Radiative transport-based frequency-domain fluorescence
tomography." Physics in medicine and biology 53.8 (2008): 2069.
109. Wang, Lihong, and Steven L. Jacques. "Hybrid model of Monte Carlo simulation
and diffusion theory for light reflectance by turbid media." JOSA A10.8 (1993):
1746-1752.
110. Wang, Lihong, Steven L. Jacques, and Liqiong Zheng. "MCML—Monte Carlo
modeling of light transport in multi-layered tissues." Computer methods and
programs in biomedicine 47.2 (1995): 131-146.
111. Yoon, Gilwon, Scott A. Prahl, and Ashley J. Welch. "Accuracies of the diffusion
approximation and its similarity relations for laser irradiated biological
media." Applied Optics 28.12 (1989): 2250-2255.
112. Halas, Naomi, et al. Delivery of Nano-Tethered Therapies to Brain Metastases
of Primary Breast Cancer Using a Cellular Trojan Horse. RICE UNIV HOUSTON TX,
2014.
113. Maini, Anil Kumar. Lasers and optoelectronics: fundamentals, devices and
applications. John Wiley & Sons, 2013.
114. https://workspace.imperial.ac.uk/physics/Public/physicsdocs/about/safety/file
s/MPE-tables.pdf last accessed June 14, 2016.

146
115. Arridge, Simon R., M. Cope, and D. T. Delpy. "The theoretical basis for the
determination of optical pathlengths in tissue: temporal and frequency
analysis." Physics in medicine and biology 37.7 (1992): 1531.
116. Delpy, David T., et al. "Estimation of optical pathlength through tissue from
direct time of flight measurement." Physics in medicine and biology 33.12 (1988):
1433.
117. Chance, Britton, et al. "Phase modulation system for dual wavelength
difference spectroscopy of hemoglobin deoxygenation in tissues."OE/LASE'90,
14-19 Jan., Los Angeles, CA. International Society for Optics and Photonics, 1990.
118. Lakowicz, Joseph R., and Klaus Berndt. "Frequency-domain measurements of
photon migration in tissues." Chemical physics letters 166.3 (1990): 246-252.

APPENDICES

147
Appendix A

Validating Scattering Coefficient of Intralipid through Probe
Measurements

In order to validate the scattering properties of the intralipid solution and further
validate the results from the spectrophotometer based studies, we used the dosimetry
probe and Monte Carlo to derive the reduced scattering coefficient of the intralipid
solution. Different concentrations of intralipid were illuminated in Plexiglas cuvette
using the diffuse broad beam from the integrating sphere (connected to the laser
source). The fluence was measured by the dosimetry probe along the beam axis for each
of the solutions. We then used the Monte Carlo to derive the scattering coefficient at
which the probe measurements match the Monte Carlo along the beam axis for the
same illumination and boundary conditions. The absorption coefficient of intralipid was
assumed to be the same as of water and the anisotropy factor of 0.636 was used in the
Monte Carlo. The results are close to those obtained by the spectrophotometer method
and are shown in figure 4.

This form of measurement was an additional validation step to the spectrophotometer
method. This method however needs to be precisely calibrated as additional errors and
offsets may be caused due to mismatch in boundary conditions as well as small
differences in illumination profiles between the MC and probe measurements.
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